<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes - Tieu, J - 2017 | Cochrane Library</title> <meta content="Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes - Tieu, J - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007724.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes - Tieu, J - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007724.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007724.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes" name="citation_title"/> <meta content="Joanna Tieu" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="joanna.tieu@gmail.com" name="citation_author_email"/> <meta content="Suzette Coat" name="citation_author"/> <meta content="The University of Adelaide, Women's and Children's Hospital" name="citation_author_institution"/> <meta content="William Hague" name="citation_author"/> <meta content="The University of Adelaide, Women's and Children's Hospital" name="citation_author_institution"/> <meta content="Philippa Middleton" name="citation_author"/> <meta content="Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute" name="citation_author_institution"/> <meta content="Emily Shepherd" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD007724.pub3" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/10/18" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007724.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007724.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007724.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Diabetes Mellitus [*drug therapy]; Diabetes, Gestational [drug therapy]; Glucose Intolerance [*drug therapy]; Hypoglycemia [chemically induced]; Hypoglycemic Agents [*administration &amp; dosage]; Insulin [therapeutic use]; Metformin [therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007724.pub3&amp;doi=10.1002/14651858.CD007724.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="77cjsSG8";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007724\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007724\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","pt","ms","pl","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007724.pub3",title:"Oral anti\\u2010diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre\\u2010existing diabetes",firstPublishedDate:"Oct 18, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007724.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007724.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007724.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007724.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007724.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007724.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007724.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007724.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007724.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007724.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5594 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007724.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-sec-0119"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-sec-0033"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-sec-0034"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-sec-0080"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-sec-0113"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/table_n/CD007724StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/table_n/CD007724StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information#CD007724-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Joanna Tieu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information#CD007724-cr-0003">Suzette Coat</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information#CD007724-cr-0004">William Hague</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information#CD007724-cr-0005">Philippa Middleton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information#CD007724-cr-0006">Emily Shepherd</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information/en#CD007724-sec-0127">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 18 October 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007724.pub3">https://doi.org/10.1002/14651858.CD007724.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007724-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007724-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007724-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007724-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007724-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007724-abs-0001" lang="en"> <section id="CD007724-sec-0001"> <h3 class="title" id="CD007724-sec-0001">Background</h3> <p>While most guidance recommends the use of insulin in women whose pregnancies are affected by pre‐existing diabetes, oral anti‐diabetic agents may be more acceptable to women. The effects of these oral anti‐diabetic agents on maternal and infant health outcomes need to be established in pregnant women with pre‐existing diabetes or impaired glucose tolerance, as well as in women with previous gestational diabetes mellitus preconceptionally or during a subsequent pregnancy. This review is an update of a review that was first published in 2010. </p> </section> <section id="CD007724-sec-0002"> <h3 class="title" id="CD007724-sec-0002">Objectives</h3> <p>To investigate the effects of oral anti‐diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who are planning a pregnancy, or pregnant women with pre‐existing diabetes, on maternal and infant health. The use of oral anti‐diabetic agents for the management of gestational diabetes in a current pregnancy is evaluated in a separate Cochrane Review. </p> </section> <section id="CD007724-sec-0003"> <h3 class="title" id="CD007724-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 October 2016) and reference lists of retrieved studies. </p> </section> <section id="CD007724-sec-0004"> <h3 class="title" id="CD007724-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) and quasi‐RCTs assessing the effects of oral anti‐diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who were planning a pregnancy, or pregnant women with pre‐existing diabetes. Cluster‐RCTs were eligible for inclusion, but none were identified. </p> </section> <section id="CD007724-sec-0005"> <h3 class="title" id="CD007724-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed study eligibility, extracted data and assessed the risk of bias of the included RCTs. Review authors checked the data for accuracy, and assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD007724-sec-0006"> <h3 class="title" id="CD007724-sec-0006">Main results</h3> <p>We identified six RCTs (707 women), eligible for inclusion in this updated review, however, three RCTs had mixed populations (that is, they included pregnant women with gestational diabetes) and did not report data separately for the relevant subset of women for this review. Therefore we have only included outcome data from three RCTs; data were available for 241 women and their infants. The three RCTs all compared an oral anti‐diabetic agent (metformin) with insulin. The women in the RCTs that contributed data had type 2 diabetes diagnosed before or during their pregnancy. Overall, the RCTs were judged to be at varying risk of bias. We assessed the quality of the evidence for selected important outcomes using GRADE; the evidence was low‐ or very low‐quality, due to downgrading because of design limitations (risk of bias) and imprecise effect estimates (for many outcomes only one or two RCTs contributed data). </p> <p>For our primary outcomes there was no clear difference between metformin and insulin groups for pre‐eclampsia (risk ratio (RR) 0.63, 95% confidence interval (CI) 0.33 to 1.20; RCTs = 2; participants = 227; very low‐quality evidence) although in one RCT women receiving metformin were less likely to have pregnancy‐induced hypertension (RR 0.58, 95% CI 0.37 to 0.91; RCTs = 1; participants = 206; low‐quality evidence). Women receiving metformin were less likely to have a caesarean section compared with those receiving insulin (RR 0.73, 95% CI 0.61 to 0.88; RCTs = 3; participants = 241; low‐quality evidence). In one RCT there was no clear difference between groups for large‐for‐gestational‐age infants (RR 1.12, 95% CI 0.73 to 1.72; RCTs = 1; participants = 206; very low‐quality evidence<i>).</i> There were no perinatal deaths in two RCTs (very low‐quality evidence). Neonatal mortality or morbidity composite outcome and childhood/adulthood neurosensory disability were not reported. </p> <p>For other secondary outcomes we assessed using GRADE, there were no clear differences between metformin and insulin groups for induction of labour (RR 1.42, 95% CI 0.62 to 3.28; RCTs = 2; participants = 35; very low‐quality evidence), though infant hypoglycaemia was reduced in the metformin group (RR 0.34, 95% CI 0.18 to 0.62; RCTs = 3; infants = 241; very low‐quality evidence). Perineal trauma, maternal postnatal depression and postnatal weight retention, and childhood/adulthood adiposity and diabetes were not reported. </p> </section> <section id="CD007724-sec-0007"> <h3 class="title" id="CD007724-sec-0007">Authors' conclusions</h3> <p>There are insufficient RCT data to evaluate the use of oral anti‐diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who are planning a pregnancy, or in pregnant women with pre‐existing diabetes. Low to very low‐quality evidence suggests possible reductions in pregnancy‐induced hypertension, caesarean section birth and neonatal hypoglycaemia with metformin compared with insulin for women with type 2 diabetes diagnosed before or during their pregnancy, and no clear differences in pre‐eclampsia, induction of labour and babies that are large‐for‐gestational age. Further high‐quality RCTs that compare any combination of oral anti‐diabetic agent, insulin and dietary and lifestyle advice for these women are needed. Future RCTs could be powered to evaluate effects on short‐ and long‐term clinical outcomes; such RCTs could attempt to collect and report on the standard outcomes suggested in this review. We have identified three ongoing studies and four are awaiting classification. We will consider these when this review is updated. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007724-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007724-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007724-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007724-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007724-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007724-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD007724-abs-0006">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD007724-abs-0004">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007724-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007724-abs-0002" lang="en"> <h3>Oral anti‐diabetic agents for women with diabetes or previous diabetes planning a pregnancy, or pregnant women with pre‐existing diabetes </h3> <p><b>What is the issue?</b> </p> <p>Pre‐existing diabetes and gestational diabetes can increase the risks of a number of poor outcomes for both mothers and their babies. For the mother, these include pregnancy‐induced high blood pressure (pre‐eclampsia) with additional fluid retention and protein in the urine; and giving birth by caesarean. For the infant, these can include preterm birth; as well as an increased risk of the presence of physical defects at birth such as heart defects, brain, spine, and spinal cord defects, Down syndrome; and spontaneous abortion. Other complications at birth include babies that are large for their gestational age, and obstructed labour (shoulder dystocia) caused by one of the shoulders becoming stuck in the birth canal once the baby's head has been born. </p> <p><b>Why is this important?</b> </p> <p>Being pregnant can trigger diabetes (gestational diabetes) in women with impaired glucose tolerance. Women who have had gestational diabetes are at risk of developing diabetes later in life. This means that management is important for women with impaired glucose tolerance or previous gestational diabetes, as well as for women with established diabetes. Women with established diabetes need good blood sugar control before they become pregnant. Insulin gives good blood sugar control and does not affect the development of the baby, but women may find oral anti‐diabetic agents more convenient and acceptable than insulin injections. However little is known about the effects of these oral agents. </p> <p>This review sought to investigate the effects of oral anti‐diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who were planning a pregnancy, or pregnant women with pre‐existing diabetes, on maternal and infant health. This review is an update of a review that was first published in 2010. </p> <p><b>What evidence did we find?</b> </p> <p>We searched for evidence from randomised controlled trials (RCTs) on 31 October 2016 and included six RCTs (707 women). Three RCTs included women with current gestational diabetes and did not report data separately for the population of women relevant to this review. Therefore we have only included outcome data from three RCTs, involving 241 pregnant women and their infants. The quality of the evidence was assessed as being low or very low and the overall risk of bias of the RCTs was varied. The three RCTs all compared an oral anti‐diabetic agent (metformin) with insulin in pregnant women with pre‐existing (type 2) diabetes. </p> <p>There was no clear difference in the development of pre‐eclampsia (high blood pressure and protein in the urine) for women who received metformin compared with insulin (2 RCTs; 227 women; very low‐quality evidence), though women receiving metformin were less likely to have pregnancy‐induced high blood pressure in one RCT (206 women; low‐quality evidence). Women who received metformin were less likely to have a caesarean section birth (3 RCTs; 241 women; low‐quality evidence), though no difference was observed in induction of labour (2 RCTs; 35 women; very low‐quality evidence). There was no clear difference between groups of infants born to mothers who received metformin or insulin for being large‐for‐gestational age (1 RCT; 206 infants; very low‐quality evidence), though infants born to mothers who received metformin were less likely to have low blood sugar (hypoglycaemia) (3 RCTs; 241 infants; very low‐quality evidence). There were no infant deaths (before birth or shortly afterwards) (2 RCTs; very low‐quality evidence). The RCTs did not report on many important short‐ and long‐term outcomes, including perineal trauma and a combined outcome of infant death or morbidity, postnatal depression and weight retention for mothers, and adiposity or disability in childhood or adulthood for infants. </p> <p><b>What does this mean?</b> </p> <p>There is not enough evidence to guide us on the effects of oral anti‐diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who are planning a pregnancy, or pregnant women with pre‐existing diabetes. Further large, well‐designed, RCTs are required and could assess and report on the outcomes suggested in this review, including both short‐ and long‐term outcomes for mothers and their infants. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007724-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007724-sec-0119"></div> <h3 class="title" id="CD007724-sec-0120">Implications for practice</h3> <section id="CD007724-sec-0120"> <p>There is currently insufficient evidence to evaluate the use of oral anti‐diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes planning a pregnancy or pregnant women with pre‐existing diabetes. Low‐ to very‐low quality evidence suggests possible reductions in pregnancy‐induced hypertension, caesarean section birth and neonatal hypoglycaemia with metformin (an oral anti‐diabetic agent) compared with insulin in pregnant women with type 2 diabetes, and no clear differences in pre‐eclampsia, induction of labour or babies who are large‐for‐gestational age. Therefore, decisions about the use of oral anti‐diabetic agents for these women will probably depend on factors such as women's preferences, available resources, and local or national clinical practice guidelines. </p> </section> <h3 class="title" id="CD007724-sec-0121">Implications for research</h3> <section id="CD007724-sec-0121"> <p>Despite limited evidence of the effects of oral anti‐diabetic agents for women included in this review, the potential benefits relating to women's acceptability and adherence with oral anti‐diabetic agents suggest that further evidence is required. Large, high‐quality randomised controlled trials are required to evaluate the effects of oral anti‐diabetic agents in women with established diabetes, impaired glucose tolerance, or previous gestational diabetes who are planning a pregnancy and pregnant women with pre‐existing diabetes. In particular, trials could compare oral anti‐diabetic agents with insulin or dietary and lifestyle control, and compare different oral anti‐diabetic agents. Trials could attempt to collect and report on the standard outcomes suggested in this review, such as short‐term maternal and infant outcomes including glycaemic control parameters and women's views, long‐term maternal and infant outcomes, and outcomes relating to the use and costs of health services. We have identified three ongoing studies, and four are awaiting classification. We will consider these in the next update of this review. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007724-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007724-sec-0022"></div> <div class="table" id="CD007724-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Maternal outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Maternal outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with type 2 diabetes<br/> <b>Setting:</b> USA (2 RCTs), Pakistan (1 RCT)<br/> <b>Intervention:</b> oral anti‐diabetic agent (metformin)<br/> <b>Comparison:</b> insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oral anti‐diabetic (metformin)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypertensive disorders of pregnancy: pre‐eclampsia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.63<br/> (0.33 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>227<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>186 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117 per 1000<br/> (61 to 223) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypertensive disorders of pregnancy: pregnancy‐induced hypertension</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/> (0.37 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>206<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1000<br/> (133 to 328) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.73<br/> (0.61 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>241<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>765 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>558 per 1000<br/> (466 to 673) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of labour</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.42<br/> (0.62 to 3.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>35<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>316 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>448 per 1000<br/> (196 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perineal trauma</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Postnatal depression</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported these outcomes</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Postnatal weight retention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported these outcomes</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Study limitations (‐2): most of the weight in this analysis was from 1 RCT with very serious design limitations </p> <p><sup>2</sup> Imprecision (‐2): wide 95% CI crossing the line of no effect and small sample sizes of RCTs </p> <p><sup>3</sup> Study limitations (‐2): 1 RCT with very serious design limitations contributed data </p> <p><sup>4</sup> Study limitations (‐1): 2 RCTs with design limitations contributed data </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007724-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Infant outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Infant outcomes: oral anti‐diabetic (metformin) compared with insulin for women with established diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with type 2 diabetes mellitus<br/> <b>Setting:</b> USA (2 RCTs) and Pakistan (1 RCT)<br/> <b>Intervention:</b> oral anti‐diabetic agent (metformin)<br/> <b>Comparison:</b> insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oral anti‐diabetic (metformin)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Large‐for‐gestational age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.12<br/> (0.73 to 1.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>206<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>270 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>302 per 1000<br/> (197 to 464) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>220<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No perinatal mortality in the 2 RCTs</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypoglycaemia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.34<br/> (0.18 to 0.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>241<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>277 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>94 per 1000<br/> (50 to 172) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neonatal mortality or morbidity composite</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Childhood/adulthood neurosensory disability</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Childhood/adulthood adiposity</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Childhood/adulthood diabetes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Study limitations (‐2): 1 RCT with very serious design limitations contributed data </p> <p><sup>2</sup> Imprecision (‐2): wide 95% CI crossing the line of no effect and small sample size of RCT </p> <p><sup>3</sup> Study limitations (‐1): 2 RCTs with design limitations contributed data </p> <p><sup>4</sup> Imprecision (‐2): no events </p> <p><sup>5</sup> Study limitations (‐2): most of the weight in this analysis was from 1 RCT with very serious design limitations </p> <p><sup>6</sup> Imprecision (‐1): small sample sizes of RCTs </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007724-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007724-sec-0023"></div> <section id="CD007724-sec-0024"> <h3 class="title" id="CD007724-sec-0024">Description of the condition</h3> <section id="CD007724-sec-0025"> <h4 class="title">Established diabetes prior to pregnancy and pre‐existing diabetes in pregnancy</h4> <p>Pre‐existing (pregestational) diabetes affects pregnant women who have been diagnosed with type 1 or type 2 diabetes ‐ or, in rare cases, other forms of diabetes mellitus ‐ prior to becoming pregnant. While some parts of the world have a significantly higher prevalence of established diabetes than others, in 2015 it was estimated that globally one in 11 (9%) adults aged 20 to 79 years ‐ that is 415 million ‐ had diabetes; this is projected to reach one in 10 (10%) ‐ or 642 million ‐ by 2040 (<a href="./references#CD007724-bbs2-0063" title="International Diabetes Federation (IDF). IDF Diabetes Atlas. 7th Edition. Brussels: International Diabetes Federation, 2015. ">IDF 2015</a>). An additional 193 million adults are estimated to have undiagnosed diabetes, and a further 318 million, are estimated to have impaired glucose tolerance, which puts them at high risk of developing the disease (<a href="./references#CD007724-bbs2-0063" title="International Diabetes Federation (IDF). IDF Diabetes Atlas. 7th Edition. Brussels: International Diabetes Federation, 2015. ">IDF 2015</a>). In 2015, it was estimated that 20.9 million, or 16.2% of live births globally were affected by some form of hyperglycaemia in pregnancy ‐ 14.9% (or approximately 3.1 million) of these pregnancies were affected by type 1 or 2 diabetes first detected in pregnancy, or detected prior to pregnancy (established diabetes) (<a href="./references#CD007724-bbs2-0063" title="International Diabetes Federation (IDF). IDF Diabetes Atlas. 7th Edition. Brussels: International Diabetes Federation, 2015. ">IDF 2015</a>). Prevalence estimates of pre‐existing diabetes in pregnancy have previously been reported as approximately 1% (<a href="./references#CD007724-bbs2-0039" title="BellR , BaileyK , CresswellT , HawthorneG , CritchleyJ , Lewis‐BarnedN , et al. Trends in prevalence and outcomes of pregnancy in women with pre‐existing type I and type II diabetes. BJOG: an international journal of obstetrics and gynaecology2008;115(4):445‐52. ">Bell 2008</a>; <a href="./references#CD007724-bbs2-0050" title="CorreaA , BardenheierB , ElixhauserA , GeissLS , GreggE . Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993–2009. Maternal and Child Health Journal2015;19:635‐42. ">Correa 2015</a>; <a href="./references#CD007724-bbs2-0075" title="LawrenceJM , ContrerasR , ChenW , SacksDA . Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999‐2005. Diabetes Care2008;31(5):899‐904. ">Lawrence 2008</a>), but prevalence is known to be increasing rapidly, with concurrent rises in obesity and type 2 diabetes. </p> <p>In addition to the impact of diabetes on health, pre‐existing diabetes in pregnancy is commonly associated with a number of adverse health outcomes for mothers and their infants. For pregnant women, pre‐existing diabetes has been associated with caesarean section, pregnancy‐induced hypertension or pre‐eclampsia, and preterm birth (<a href="./references#CD007724-bbs2-0074" title="LangerO , ConwayDL , BerkusMD , XenakisEM , GonzalesO . A comparison of glyburide and insulin in women with gestational diabetes mellitus. New England Journal of Medicine2000;343(16):1134‐8. ">Langer 2000a</a>; <a href="./references#CD007724-bbs2-0087" title="RayJG , VermeulenMJ , ShapiroJL , KensholeAB . Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. Quarterly Journal of Medicine2001;94:347‐56. ">Ray 2001</a>; <a href="./references#CD007724-bbs2-0099" title="WalkinshawSA . Pregnancy in women with pre‐existing diabetes: management issues. Seminars in Fetal &amp; Neonatal Medicine2005;10:307‐15. ">Walkinshaw 2005</a>). Pregnancy in women with pre‐existing diabetes may also exacerbate the effects of diabetes on renal function and retinopathy (<a href="./references#CD007724-bbs2-0076" title="LeguizamonG , IgarzabalML , ReeceEA . Preconceptional care of women with diabetes mellitus. Obstetrics and Gynecology Clinics of North America2007;34(2):225‐39. ">Leguizamon 2007</a>; <a href="./references#CD007724-bbs2-0091" title="ShethB . Does pregnancy accelerate the rate of progression of diabetic retinopathy?. Current Diabetes Report2002;23(8):327‐30. ">Sheth 2002</a>). Pre‐existing diabetes in pregnancy is associated with an increased risk of fetal congenital anomaly and spontaneous abortion (<a href="./references#CD007724-bbs2-0070" title="KitzmillerJL , BuchananTA , KjosS , CombsCA , RatnerRE . Pre‐conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care1996;19(5):514‐41. ">Kitzmiller 1996</a>). Fetal hyperinsulinaemia associated with pre‐existing diabetes may affect infants by increasing the incidence of: macrosomia (birthweight exceeding 4000 g); large‐for‐gestational age (birthweight greater than 90th centile for age); shoulder dystocia; neonatal hypoglycaemia; preterm birth; hyperbilirubinaemia; hypocalcaemia, and neonatal intensive care admission (<a href="./references#CD007724-bbs2-0064" title="JensenDM , DamP , Moelsted‐PedersenL , OvesenP , WestergaardJG , MoellerM , et al. Outcomes in type 1 diabetic pregnancies. Diabetes Care2004;27(12):2819‐23. ">Jensen 2004</a>; <a href="./references#CD007724-bbs2-0077" title="MacintoshMC , FlemingKM , BaileyJA , DoyleP , ModderJ , AcoletD , et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ2006;333(7560):177. ">Macintosh 2006</a>; <a href="./references#CD007724-bbs2-0087" title="RayJG , VermeulenMJ , ShapiroJL , KensholeAB . Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. Quarterly Journal of Medicine2001;94:347‐56. ">Ray 2001</a>; <a href="./references#CD007724-bbs2-0099" title="WalkinshawSA . Pregnancy in women with pre‐existing diabetes: management issues. Seminars in Fetal &amp; Neonatal Medicine2005;10:307‐15. ">Walkinshaw 2005</a>; <a href="./references#CD007724-bbs2-0100" title="WeintrobN , KarpM , HodM . Short‐ and long‐ range complications in offspring of diabetic mothers. Journal of Diabetes and its Complications1996;10:294‐301. ">Weintrob 1996</a>). Furthermore, long‐term follow‐up of infants of diabetic mothers suggests that exposure to maternal diabetes in utero increases the risk of obesity and type 2 diabetes for these children in the future (<a href="./references#CD007724-bbs2-0052" title="DabeleaD , KnowlerWC , PettittDJ . Effect of diabetes in pregnancy on offspring: follow‐up research in the Pima Indians. Journal of Maternal‐Fetal Medicine2000;9:83‐8. ">Dabelea 2000</a>). </p> </section> <section id="CD007724-sec-0026"> <h4 class="title">Previous gestational diabetes</h4> <p>Gestational diabetes mellitus is defined as "carbohydrate intolerance resulting in hyperglycaemia of variable severity with onset or first recognition during pregnancy" (<a href="./references#CD007724-bbs2-0101" title="World Health Organization. Report of a WHO consultation: definition, diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999. ">WHO 1999</a>). The reported incidence of gestational diabetes varies between different populations and the method and criteria by which the diagnosis is made, with studies estimating incidence rates that range between 1% and 28% (<a href="./references#CD007724-bbs2-0065" title="JiwaniA , MarseilleE , LohseN , DammP , HodM , KahnJG . Gestational diabetes mellitus: results from a survey of country prevalence and practices. Journal of Maternal Fetal and Neonatal Medicine2012;25(6):600‐10. ">Jiwani 2012</a>). Gestational diabetes is associated with an increased risk of a number of adverse perinatal outcomes including macrosomia, shoulder dystocia, perineal trauma, pre‐eclampsia, and neonatal hypoglycaemia (<a href="./references#CD007724-bbs2-0088" title="ReeceEA . The fetal and maternal consequences of gestational diabetes mellitus. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(3):199‐203. ">Reece 2010</a>). Although gestational diabetes resolves in 90% of cases, women with a history of gestational diabetes represent a unique group of women who are at significant risk for developing recurrent gestational diabetes and later established diabetes (<a href="./references#CD007724-bbs2-0068" title="KimC , NewtonKM , KnoppRH . Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care2002;25:1862‐8. ">Kim 2002</a>; <a href="./references#CD007724-bbs2-0069" title="KimC , BergerDK , ChamanyS . Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care2007;30:1314‐9. ">Kim 2007</a>). It has been estimated that there is a 2% risk of progression to established diabetes in the subsequent pregnancy for women with gestational diabetes (<a href="./references#CD007724-bbs2-0067" title="KhambaliaAZ , FordJB , NassarN , ShandAW , McElduffA , RobertsCL . Occurrence and recurrence of diabetes in pregnancy. Diabetic Medicine2013;30:452‐6. ">Khambalia 2013</a>). </p> <p>Despite the potential need for intervention for these groups of women, there is limited evidence about the use of oral anti‐diabetic agents preconceptionally or during pregnancy. </p> </section> </section> <section id="CD007724-sec-0027"> <h3 class="title" id="CD007724-sec-0027">Description of the intervention</h3> <section id="CD007724-sec-0028"> <h4 class="title">Management of established diabetes before pregnancy, and pre‐existing diabetes during pregnancy </h4> <p>The occurrence of adverse outcomes in women with pre‐existing diabetes and their infants is inversely related to the level of glycaemic control achieved during pregnancy. Therefore, there is a strong focus on the management of maternal glucose concentrations in preconception and antenatal care of women with established diabetes. </p> <p>Prior to conception, it is recommended that women with established diabetes receive multidisciplinary care including an assessment of diabetes complications, advice on glycaemic control, diet, the importance of family planning, maternal diabetes complications and fetal risks (<a href="./references#CD007724-bbs2-0036" title="American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care2015;38(Suppl 1):S77‐S79. ">ADA 2015</a>; <a href="./references#CD007724-bbs2-0037" title="McElduffA , CheungNW , McIntyreHD , LagstromJA , OatsJJ , RossGP , et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Medical Journal of Australia2005;183(7):373‐7. ">ADIPS 2005</a>; <a href="./references#CD007724-bbs2-0047" title="Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Canadian Diabetes Association. 2013 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes2013;37(Suppl 1):S1‐S212. ">CDA 2013</a>; <a href="./references#CD007724-bbs2-0083" title="National Institute for Health and Clinical Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. London: NICE, 2015. ">NICE 2015</a>). Oral anti‐diabetic agents are more commonly used by people with type 2 diabetes than people with type 1 diabetes, who commonly will not achieve adequate glycaemic control on oral anti‐diabetics alone. Currently, it is recommended that oral anti‐diabetic agents be substituted for insulin in women planning pregnancy and during pregnancy (<a href="./references#CD007724-bbs2-0036" title="American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care2015;38(Suppl 1):S77‐S79. ">ADA 2015</a>; <a href="./references#CD007724-bbs2-0037" title="McElduffA , CheungNW , McIntyreHD , LagstromJA , OatsJJ , RossGP , et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Medical Journal of Australia2005;183(7):373‐7. ">ADIPS 2005</a>; <a href="./references#CD007724-bbs2-0047" title="Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Canadian Diabetes Association. 2013 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes2013;37(Suppl 1):S1‐S212. ">CDA 2013</a>; <a href="./references#CD007724-bbs2-0083" title="National Institute for Health and Clinical Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. London: NICE, 2015. ">NICE 2015</a>). </p> <p>Oral anti‐diabetic agents, also referred to as oral hypoglycaemic agents or oral antihyperglycaemic agents, act in a variety of ways. While widely used in men and women with type 2 diabetes, their use in women with established diabetes who are planning a pregnancy or are pregnant has been controversial, with conflicting reports about their safety. As a result of these concerns, insulin has been the preferred agent for glycaemic management in women with pre‐existing diabetes during pregnancy (<a href="./references#CD007724-bbs2-0036" title="American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care2015;38(Suppl 1):S77‐S79. ">ADA 2015</a>; <a href="./references#CD007724-bbs2-0037" title="McElduffA , CheungNW , McIntyreHD , LagstromJA , OatsJJ , RossGP , et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Medical Journal of Australia2005;183(7):373‐7. ">ADIPS 2005</a>; <a href="./references#CD007724-bbs2-0047" title="Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Canadian Diabetes Association. 2013 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes2013;37(Suppl 1):S1‐S212. ">CDA 2013</a>; <a href="./references#CD007724-bbs2-0083" title="National Institute for Health and Clinical Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. London: NICE, 2015. ">NICE 2015</a>). Current recommendations suggest that women planning or continuing a pregnancy use insulin, although oral anti‐diabetic agents may be considered on an individual basis, since the harm from uncontrolled diabetes may outweigh any potential harm from the oral agents. </p> <p>Lack of safety data for the use of oral anti‐diabetic agents in pregnancy has prevented them from being routinely recommended for use during pregnancy. It has also been argued that the use of oral anti‐diabetic agents alone, including glyburide (glibenclamide) and metformin, may be inadequate to manage the post‐prandial glycaemic peaks associated with type 2 diabetes successfully (<a href="./references#CD007724-bbs2-0066" title="JovanovicL . Point: oral hypoglycemic agents should not be used to treat diabetic pregnant women. Diabetes Care2007;30:2976‐9. ">Jovanovic 2007</a>). However, oral anti‐diabetic agents are convenient, may be preferable to insulin injections, and may not require the intensive education associated with insulin therapy. Where oral agents alone are not sufficient to achieve glycaemic control, they may be used in combination to reduce the frequency or dose of insulin. </p> <p>A retrospective study of women in South Africa with established diabetes, who remained on oral anti‐diabetic agents, transferred from oral agents to insulin, or transferred from diet alone to insulin, reported no difference in fetal anomaly rates (<a href="./references#CD007724-bbs2-0055" title="EkpebeghCO , CoetzeeEJ , Van derMerweL , LevittNS . A 10‐year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose‐lowering agents. Diabetic Medicine2007;24:253‐8. ">Ekpebegh 2007</a>). This study, however, did report a significantly higher perinatal mortality rate for women continuing on oral anti‐diabetic agents alone compared with women who received insulin. Meta‐analyses and reviews of observational studies have been unable to provide definitive conclusions about the effects of oral anti‐diabetic agents in pregnancy (<a href="./references#CD007724-bbs2-0058" title="GutzinSJ , KozerE , MageeLA , FeigDS , KorenG . The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta‐analysis. Canadian Journal of Clinical Pharmacology2003;10(4):179‐83. ">Gutzin 2003</a>; <a href="./references#CD007724-bbs2-0061" title="HoFL , LiewCF , CunananEC , LeeKO . Oral hypoglycaemic agents for diabetes in pregnancy: an appraisal of the current evidence for oral anti‐diabetic drug use in pregnancy. Annals of the Academy of Medicine, Singapore2007;36:672‐8. ">Ho 2007</a>). </p> <p>The <a href="./references#CD007724-bbs2-0097" title="TieuJ , MiddletonP , CrowtherCA , ShepherdE . Preconception care for diabetic women for improving maternal and infant health. Cochrane Database of Systematic Reviews2017, Issue 8. [DOI: 10.1002/14651858.CD007776.pub3] ">Tieu 2017</a> Cochrane Review found no evidence of benefit for preconception care compared with no preconception care, or any protocol of preconception care over another, for women with established diabetes. Cochrane Reviews have also assessed various management strategies during pregnancy for women with pre‐existing diabetes. The <a href="./references#CD007724-bbs2-0085" title="O'NeillSM , KennyLC , KhashanAS , WestHM , SmythRM , KearneyPM . Different insulin types and regimens for pregnant women with pre‐existing diabetes. Cochrane Database of Systematic Reviews2017, Issue 2. [DOI: 10.1002/14651858.CD011880.pub2] ">O'Neill 2017</a> Cochrane Review, which assessed different insulin types and regimens, recently concluded that no firm conclusions could be drawn on the basis of current evidence. The <a href="./references#CD007724-bbs2-0056" title="FarrarD , TuffnellDJ , WestJ , WestHM . Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database of Systematic Reviews2016, Issue 6. [DOI: 10.1002/14651858.CD005542.pub3] ">Farrar 2016</a> Cochrane Review similarly concluded that there is currently no evidence to support the use of one particular form of insulin administration over another. Furthermore, reviews of different intensities of glycaemic control (<a href="./references#CD007724-bbs2-0080" title="MiddletonP , CrowtherCA , SimmondsL . Different intensities of glycaemic control for pregnant women with pre‐existing diabetes. Cochrane Database of Systematic Reviews2016, Issue 5. [DOI: 10.1002/14651858.CD008540.pub4] ">Middleton 2016</a>), and techniques of monitoring blood glucose for women with pre‐existing diabetes in pregnancy (<a href="./references#CD007724-bbs2-0081" title="MoyFM , RayA , BuckleyBS . Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD009613.pub2] ">Moy 2014</a>), have not been able to reach firm conclusions about best practice either. </p> </section> <section id="CD007724-sec-0029"> <h4 class="title">Management of previous gestational diabetes before and during pregnancy</h4> <p>While the importance of management for women with gestational diabetes has been recognised (<a href="./references#CD007724-bbs2-0051" title="CrowtherC , HillerJ , MossJ , McPheeA , JeffriesW , RobinsonJ , et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine2005;352:2477‐86. ">Crowther 2005</a>; <a href="./references#CD007724-bbs2-0073" title="LandonMB , SpongCY , ThornE , CarpenterMW , RaminSM , CaseyB , et al. A multicenter, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine2009;361(14):1339‐48. ">Landon 2009</a>), the most appropriate form of treatment is uncertain (<a href="./references#CD007724-bbs2-0038" title="AlwanN , TuffnellDJ , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a>). The Cochrane Review 'Treatment for gestational diabetes' concluded that while women with gestational diabetes should be considered for specific treatment in addition to routine antenatal care, the decision about whether to offer dietary advice or more intensive treatment (including insulin or oral agents) was unclear (<a href="./references#CD007724-bbs2-0038" title="AlwanN , TuffnellDJ , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a>), as were the effects on long‐term outcomes for the women and their infants (<a href="./references#CD007724-bbs2-0038" title="AlwanN , TuffnellDJ , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a>). This review assessed a range of management options, including the use of oral anti‐diabetic agents such as metformin and glyburide (glibenclamide). The review found that women who received oral anti‐diabetic agents compared with insulin were less likely to have a caesarean section, and their infants were less likely to develop neonatal hypoglycaemia; there were however, no differences in other important outcomes such as induction of labour and shoulder dystocia (<a href="./references#CD007724-bbs2-0038" title="AlwanN , TuffnellDJ , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a>). </p> <p>The <a href="./references#CD007724-bbs2-0038" title="AlwanN , TuffnellDJ , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a> Cochrane Review has now been separated into reviews that address lifestyle interventions (<a href="./references#CD007724-bbs2-0044" title="BrownJ , AlwanNA , WestJ , BrownS , McKinlayCJ , FarrarD , et al. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2017, Issue 5. [DOI: 10.1002/14651858.CD011970.pub2] ">Brown 2017a</a>), dietary supplementation with myo‐inositol (<a href="./references#CD007724-bbs2-0042" title="BrownJ , CrawfordTJ , AlsweilerJ , CrowtherCA . Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes. Cochrane Database of Systematic Reviews2016, Issue 9. [DOI: 10.1002/14651858.CD012048.pub2] ">Brown 2016a</a>), different intensities of glycaemic control (<a href="./references#CD007724-bbs2-0079" title="MartisR , BrownJ , AlsweilerJ , CrawfordTJ , CrowtherCA . Different intensities of glycaemic control for women with gestational diabetes mellitus. Cochrane Database of Systematic Reviews2016, Issue 4. [DOI: 10.1002/14651858.CD011624.pub2] ">Martis 2016</a>), as well as insulin (<a href="./references#CD007724-bbs2-0043" title="BrownJ , GrzeskowiakL , WilliamsonK , DownieMR , CrowtherCA . Insulin for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD012037] ">Brown 2016b</a>), and oral anti‐diabetic agents (<a href="./references#CD007724-bbs2-0045" title="BrownJ , MartisR , HughesB , RowanJ , CrowtherCA . Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD011967.pub2] ">Brown 2017b</a>). The recent <a href="./references#CD007724-bbs2-0045" title="BrownJ , MartisR , HughesB , RowanJ , CrowtherCA . Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD011967.pub2] ">Brown 2017b</a> review concluded that there are insufficient data from comparisons of oral anti‐diabetic agents versus placebo/standard care (lifestyle advice) in women with gestational diabetes to inform clinical practice, or to draw any meaningful conclusions regarding the benefits or harms of one oral anti‐diabetic agent over another (e.g. metformin versus glibenclamide; and glibenclamide versus acarbose) (<a href="./references#CD007724-bbs2-0045" title="BrownJ , MartisR , HughesB , RowanJ , CrowtherCA . Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD011967.pub2] ">Brown 2017b</a>). The <a href="./references#CD007724-bbs2-0043" title="BrownJ , GrzeskowiakL , WilliamsonK , DownieMR , CrowtherCA . Insulin for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD012037] ">Brown 2016b</a> review, which will include comparisons of oral anti‐diabetic agents with insulin is currently being prepared. </p> <p>The <a href="./references#CD007724-bbs2-0096" title="TieuJ , BainE , MiddletonP , CrowtherCA . Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD010211.pub2] ">Tieu 2013</a> Cochrane Review found no evidence to assess the role of interconception care for women with a history of gestational diabetes. </p> </section> </section> <section id="CD007724-sec-0030"> <h3 class="title" id="CD007724-sec-0030">How the intervention might work</h3> <section id="CD007724-sec-0031"> <h4 class="title">Oral anti‐diabetic agents</h4> <p>Common anti‐diabetic agents include sulfonylureas, biguanides, thiazolidinediones, alpha‐glucosidase inhibitors, meglitinides and peptide analogues. Biguanides, including metformin, reduce peripheral insulin resistance, inhibit gluconeogenesis and reduce plasma triglyceride concentrations (<a href="./references#CD007724-bbs2-0054" title="DeFronzoRA , GoodmanAM , the Multicenter Metformin Study Group. Efficacy of metformin in patients with non‐insulin‐dependent diabetes mellitus. New England Journal of Medicine1995;333(9):541‐9. ">DeFronzo 1995</a>; <a href="./references#CD007724-bbs2-0095" title="StumvollM , NurjhanN , PerrielloG , DaileyG , GerichJE . Metabolic effects of metformin in non‐insulin‐dependent diabetes mellitus. New England Journal of Medicine1995;333(9):588‐9. ">Stumvoll 1995</a>; <a href="./references#CD007724-bbs2-0102" title="YogevY , LangerO . The use of anti‐hyperglycaemic and hypoglycaemic agents in pregnancy. Fetal and Maternal Medicine Review2004;15(2):133‐43. ">Yogev 2004</a>). Since metformin does cross the placenta, there have been concerns about its use in pregnancy (<a href="./references#CD007724-bbs2-0059" title="HellmuthE , DammP , Molsted‐PedersenL . Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabetic Medicine2000;17(7):507‐11. ">Hellmuth 2000</a>; <a href="./references#CD007724-bbs2-0071" title="KovoM , HaroutinunianS , FeldmanN , HoffmanA , GlezermanM . Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotelydon model. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2008;136(1):29‐33. ">Kovo 2007</a>; <a href="./references#CD007724-bbs2-0094" title="SlocumJM , SosaMEB . Use of antidiabetes agents in pregnancy: current practice and controversy. Journal of Perinatal and Neonatal Nursing2002;16(2):40‐53. ">Slocum 2002</a>). Since the publication of the <a href="./references#CD007724-bbs2-0038" title="AlwanN , TuffnellDJ , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a> Cochrane Review, the use of metformin for the treatment of gestational diabetes has been evaluated in a large randomised controlled trial (<a href="./references#CD007724-bbs2-0090" title="RowanJA , HagueWM , GaoW , BattinMR , MooreMP , MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. New England Journal of Medicine2008;358(19):2003‐15. ">Rowan 2008a</a>). This trial found that compared with insulin, while metformin was not associated with increased perinatal complications, it was associated with a tendency for less severe neonatal hypoglycaemia, less maternal weight gain and greater maternal acceptability. In this study metformin was commenced in the latter half of pregnancy, between 20 and 34 weeks' gestation. </p> <p>There is no definitive evidence of the safety of metformin in pregnancies complicated by pre‐existing diabetes (<a href="./references#CD007724-bbs2-0061" title="HoFL , LiewCF , CunananEC , LeeKO . Oral hypoglycaemic agents for diabetes in pregnancy: an appraisal of the current evidence for oral anti‐diabetic drug use in pregnancy. Annals of the Academy of Medicine, Singapore2007;36:672‐8. ">Ho 2007</a>). However, since it has been suggested that metformin increases the incidence of pregnancy and reduces pregnancy loss in women with polycystic ovary syndrome (PCOS), there are data available from babies born to mothers with PCOS who took metformin during pregnancy. Follow‐up at 18 months of age of 126 infants born to 109 mothers with PCOS, who conceived while taking metformin and continued to take it during pregnancy, reported that the metformin‐exposed infants were of similar size and had similar motor‐social development to infants of women not known to have PCOS (<a href="./references#CD007724-bbs2-0041" title="BrockB , SmidtK , OvesenP , SchmitzO , RungbyJ . Is metformin therapy for polycystic ovary syndrome safe during pregnancy?. Basic &amp; Clinical Pharmacology &amp; Toxicology2005;96:410‐2. ">Brock 2005</a>; <a href="./references#CD007724-bbs2-0057" title="GlueckCJ , GoldenbergN , PranikoffJ , LotspringM , SieveL , WangP . Height, weight, and motor‐social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Human Reproduction2004;19(6):1323‐30. ">Glueck 2004</a>). </p> <p>Sulfonylureas, for example glyburide (glibenclamide) and glimepiride, enhance insulin secretion and peripheral tissue sensitivity to insulin while also reducing hepatic clearance of insulin (<a href="./references#CD007724-bbs2-0053" title="DeFronzoRA , SimonsonDC . Oral sulfonylurea agents suppress hepatic glucose production in non‐insulin‐dependent diabetic individuals. Diabetes Care1984;7(Suppl 1):72‐80. ">DeFronzo 1984</a>; <a href="./references#CD007724-bbs2-0062" title="HomkoCJ , ReeceEA . Insulins and oral hypoglycemic agents in pregnancy. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(11):679‐86. ">Homko 2006</a>; <a href="./references#CD007724-bbs2-0092" title="SimonsonDC , FerranniniE , BevilacquaS , SmithD , BarrettE , CarlsonR , et al. Mechanism of improvement of glucose metabolism after chronic glyburide therapy. Diabetes1984;33(9):838‐45. ">Simonson 1984</a>; <a href="./references#CD007724-bbs2-0102" title="YogevY , LangerO . The use of anti‐hyperglycaemic and hypoglycaemic agents in pregnancy. Fetal and Maternal Medicine Review2004;15(2):133‐43. ">Yogev 2004</a>). The main side effect of these agents is hypoglycaemia, and while first generation sulfonylureas cross the placenta, it is unclear whether second generation agents, including glyburide (glibenclamide), do, and what effect this might have on the developing fetus (<a href="./references#CD007724-bbs2-0066" title="JovanovicL . Point: oral hypoglycemic agents should not be used to treat diabetic pregnant women. Diabetes Care2007;30:2976‐9. ">Jovanovic 2007</a>; <a href="./references#CD007724-bbs2-0072" title="KraemerJ , KleinJ , LubetskyA , KorenG . Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. American Journal of Obstetrics and Gynecology2006;195(1):270‐4. ">Kraemer 2006</a>; <a href="./references#CD007724-bbs2-0093" title="SivanE , FeldmanB , DolitzkiM , NevoN , DekelN , KarasikA . Glyburide crosses the placenta in vivo in pregnant rats. Diabetologia1995;38(7):753‐6. ">Sivan 1995</a>; <a href="./references#CD007724-bbs2-0094" title="SlocumJM , SosaMEB . Use of antidiabetes agents in pregnancy: current practice and controversy. Journal of Perinatal and Neonatal Nursing2002;16(2):40‐53. ">Slocum 2002</a>). The ability of sulfonylureas to stimulate fetal hyperinsulinaemia is a major concern (<a href="./references#CD007724-bbs2-0049" title="CoetzeeEJ . Counterpoint: oral hypoglycemic agents should be used to treat diabetic pregnant women. Diabetes Care2007;30:2980‐2. ">Coetzee 2007</a>). However, a randomised controlled trial of treatment of women with gestational diabetes, included in the <a href="./references#CD007724-bbs2-0038" title="AlwanN , TuffnellDJ , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a> Cochrane Review, which investigated glyburide (glibenclamide; a second generation sulfonylurea), or insulin, found that there were no differences in macrosomic or large‐for‐gestational‐age infants between the two groups (<a href="./references#CD007724-bbs2-0074" title="LangerO , ConwayDL , BerkusMD , XenakisEM , GonzalesO . A comparison of glyburide and insulin in women with gestational diabetes mellitus. New England Journal of Medicine2000;343(16):1134‐8. ">Langer 2000a</a>). </p> <p>Alpha‐glucosidase inhibitors such as acarbose and miglitol reduce postprandial glucose concentrations by decreasing the breakdown and absorption of carbohydrates in the intestine (<a href="./references#CD007724-bbs2-0094" title="SlocumJM , SosaMEB . Use of antidiabetes agents in pregnancy: current practice and controversy. Journal of Perinatal and Neonatal Nursing2002;16(2):40‐53. ">Slocum 2002</a>; <a href="./references#CD007724-bbs2-0102" title="YogevY , LangerO . The use of anti‐hyperglycaemic and hypoglycaemic agents in pregnancy. Fetal and Maternal Medicine Review2004;15(2):133‐43. ">Yogev 2004</a>). There is little evidence of the use of these agents in pregnancy (<a href="./references#CD007724-bbs2-0061" title="HoFL , LiewCF , CunananEC , LeeKO . Oral hypoglycaemic agents for diabetes in pregnancy: an appraisal of the current evidence for oral anti‐diabetic drug use in pregnancy. Annals of the Academy of Medicine, Singapore2007;36:672‐8. ">Ho 2007</a>). Alpha‐glucosidase inhibitors are typically used in combination with other oral anti‐diabetic agents or insulin (<a href="./references#CD007724-bbs2-0102" title="YogevY , LangerO . The use of anti‐hyperglycaemic and hypoglycaemic agents in pregnancy. Fetal and Maternal Medicine Review2004;15(2):133‐43. ">Yogev 2004</a>). </p> <p>Thiazolidinediones, including rosiglitazone and pioglitazone, result in increased insulin sensitivity and decreased lipid availability (<a href="./references#CD007724-bbs2-0094" title="SlocumJM , SosaMEB . Use of antidiabetes agents in pregnancy: current practice and controversy. Journal of Perinatal and Neonatal Nursing2002;16(2):40‐53. ">Slocum 2002</a>; <a href="./references#CD007724-bbs2-0102" title="YogevY , LangerO . The use of anti‐hyperglycaemic and hypoglycaemic agents in pregnancy. Fetal and Maternal Medicine Review2004;15(2):133‐43. ">Yogev 2004</a>). There is little evidence about the use of thiazolidinediones in pregnancy (<a href="./references#CD007724-bbs2-0061" title="HoFL , LiewCF , CunananEC , LeeKO . Oral hypoglycaemic agents for diabetes in pregnancy: an appraisal of the current evidence for oral anti‐diabetic drug use in pregnancy. Annals of the Academy of Medicine, Singapore2007;36:672‐8. ">Ho 2007</a>), although, placental transfer of thiazolidinediones has been reported (<a href="./references#CD007724-bbs2-0048" title="ChanLYS , YeungJH , LauTK . Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertility and Sterility2005;83(4):955‐8. ">Chan 2005</a>). Furthermore, concerns have been expressed about the use of rosiglitazone in type 2 diabetes due to an increased risk of adverse cardiovascular outcomes (<a href="./references#CD007724-bbs2-0084" title="NissenSE , WolskiK . Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New England Journal of Medicine2007;356:2457‐71. ">Nissen 2007</a>). </p> <p>Meglitinides increase pancreatic insulin secretion. There is little evidence of their use in pregnancy (<a href="./references#CD007724-bbs2-0094" title="SlocumJM , SosaMEB . Use of antidiabetes agents in pregnancy: current practice and controversy. Journal of Perinatal and Neonatal Nursing2002;16(2):40‐53. ">Slocum 2002</a>), and a similar absence of evidence for the use of peptide analogues such as incretin mimetics and dipeptidyl peptidase‐4 inhibitors. </p> </section> </section> <section id="CD007724-sec-0032"> <h3 class="title" id="CD007724-sec-0032">Why it is important to do this review</h3> <p>With the rising prevalence of type 1, type 2 and gestational diabetes, there is an increasing need for evidence‐based management of women with established diabetes or a history of gestational diabetes both preconceptionally and during pregnancy. While most guidelines recommend the use of insulin in place of oral anti‐diabetic agents, oral agents may have benefits, particularly in terms of acceptability and adherence. However, there is little evidence about the effects of these agents on maternal and infant health. It is necessary, therefore, to assess the benefits and harms of anti‐diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who are planning a pregnancy, and pregnant women with pre‐existing diabetes mellitus. The use of oral anti‐diabetic agents for the management of gestational diabetes in a current pregnancy was previously evaluated in the Cochrane Review 'Treatment of gestational diabetes' (<a href="./references#CD007724-bbs2-0038" title="AlwanN , TuffnellDJ , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a>); specific assessments of oral anti‐diabetic agents (<a href="./references#CD007724-bbs2-0045" title="BrownJ , MartisR , HughesB , RowanJ , CrowtherCA . Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD011967.pub2] ">Brown 2017b</a>), and comparisons of these agents with insulin for women with gestational diabetes (<a href="./references#CD007724-bbs2-0043" title="BrownJ , GrzeskowiakL , WilliamsonK , DownieMR , CrowtherCA . Insulin for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD012037] ">Brown 2016b</a>), are made in two new Cochrane Reviews. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007724-sec-0033" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007724-sec-0033"></div> <p>To investigate the effect of oral anti‐diabetic agents in women with established diabetes, impaired glucose tolerance or previous gestational diabetes who are planning a pregnancy, or pregnant women with pre‐existing diabetes, on maternal and infant health. The use of oral anti‐diabetic agents for the management of gestational diabetes in a current pregnancy is evaluated in a separate Cochrane Review. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007724-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007724-sec-0034"></div> <section id="CD007724-sec-0035"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007724-sec-0036"> <h4 class="title">Types of studies</h4> <p>We planned to include randomised and quasi‐randomised controlled trials, and cluster‐randomised trials, and to exclude cross‐over trials. We planned to include trials published in abstract form only where there was sufficient information available to assess study eligibility and risk of bias. </p> </section> <section id="CD007724-sec-0037"> <h4 class="title">Types of participants</h4> <p>Women with established type 1 or 2 diabetes mellitus, impaired glucose tolerance or previous gestational diabetes mellitus planning a pregnancy or pregnant women with pre‐existing type 1 or 2 diabetes mellitus. Trials involving women with gestational diabetes in a current pregnancy were excluded from this review. </p> </section> <section id="CD007724-sec-0038"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD007724-list-0001"> <li> <p>Oral anti‐diabetic agent versus no medication</p> </li> <li> <p>Oral anti‐diabetic agent versus another oral anti‐diabetic agent</p> </li> <li> <p>Oral anti‐diabetic agent versus insulin</p> </li> <li> <p>Oral anti‐diabetic agent versus insulin plus an oral anti‐diabetic agent</p> </li> <li> <p>Oral anti‐diabetic agent plus insulin versus insulin</p> </li> <li> <p>Different regimens of any of the above</p> </li> </ul> </p> </section> <section id="CD007724-sec-0039"> <h4 class="title">Types of outcome measures</h4> <p>For this update, we used the standard outcome set agreed by consensus between review authors of Cochrane Pregnancy and Childbirth systematic reviews for prevention and treatment of gestational diabetes and pre‐existing diabetes. </p> <section id="CD007724-sec-0040"> <h5 class="title">Primary outcomes</h5> <section id="CD007724-sec-0041"> <h6 class="title">Mother</h6> <p> <ul id="CD007724-list-0002"> <li> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </li> <li> <p>Caesarean section</p> </li> </ul> </p> </section> <section id="CD007724-sec-0042"> <h6 class="title">Infant/child/adult</h6> <p> <ul id="CD007724-list-0003"> <li> <p>Large‐for‐gestational age</p> </li> <li> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </li> <li> <p>Neonatal mortality or morbidity composite (e.g. perinatal mortality, shoulder dystocia, bone fracture, and admission to the neonatal unit) </p> </li> <li> <p>Childhood/adulthood neurosensory disability</p> </li> </ul> </p> </section> </section> <section id="CD007724-sec-0043"> <h5 class="title">Secondary outcomes</h5> <section id="CD007724-sec-0044"> <h6 class="title">Mother: short‐term</h6> <p> <ul id="CD007724-list-0004"> <li> <p>Spontaneous abortion/miscarriage</p> </li> <li> <p>Gestational diabetes mellitus</p> </li> <li> <p>Induction of labour</p> </li> <li> <p>Perineal trauma</p> </li> <li> <p>Placental abruption</p> </li> <li> <p>Postpartum haemorrhage</p> </li> <li> <p>Postpartum infection</p> </li> <li> <p>Weight gain during pregnancy</p> </li> <li> <p>Adherence to the intervention</p> </li> <li> <p>Sense of well‐being and quality of life</p> </li> <li> <p>Views of the intervention</p> </li> <li> <p>Adverse effects of the intervention</p> </li> <li> <p>Breastfeeding at discharge, six weeks postpartum, six months or longer</p> </li> <li> <p>Use of additional pharmacotherapy for glycaemic control</p> </li> <li> <p>Glycaemic control during/end of treatment (e.g. blood glucose or haemoglobin A1c (HbA1c))</p> </li> <li> <p>Hypoglycaemia</p> </li> <li> <p>Mortality</p> </li> <li> <p>Complications of diabetes (retinopathy, neuropathy, nephropathy, ischaemic heart disease, cerebrovascular disease, peripheral vascular disease) </p> </li> </ul> </p> </section> <section id="CD007724-sec-0045"> <h6 class="title">Mother: long‐term</h6> <p> <ul id="CD007724-list-0005"> <li> <p>Postnatal depression</p> </li> <li> <p>Postnatal weight retention or return to prepregnancy weight</p> </li> <li> <p>Body mass index (BMI)</p> </li> <li> <p>Gestational diabetes mellitus in a subsequent pregnancy</p> </li> <li> <p>Type 1 diabetes</p> </li> <li> <p>Type 2 diabetes</p> </li> <li> <p>Impaired glucose tolerance</p> </li> <li> <p>Cardiovascular health (as defined by trialists, including blood pressure, hypertension, cardiovascular disease, metabolic syndrome) </p> </li> </ul> </p> </section> <section id="CD007724-sec-0046"> <h6 class="title">Infant</h6> <p> <ul id="CD007724-list-0006"> <li> <p>Congenital anomaly</p> </li> <li> <p>Stillbirth</p> </li> <li> <p>Neonatal mortality</p> </li> <li> <p>Gestational age at birth</p> </li> <li> <p>Preterm birth (less than 37 weeks' gestation and less than 32 weeks' gestation)</p> </li> <li> <p>Apgar score (less than seven at five minutes)</p> </li> <li> <p>Macrosomia (birthweight greater than 4000 g and birthweight greater than 4500 g)</p> </li> <li> <p>Small‐for‐gestational age</p> </li> <li> <p>Birthweight and Z score</p> </li> <li> <p>Head circumference and Z score</p> </li> <li> <p>Length and Z score</p> </li> <li> <p>Ponderal index</p> </li> <li> <p>Adiposity</p> </li> <li> <p>Shoulder dystocia</p> </li> <li> <p>Bone fracture</p> </li> <li> <p>Nerve palsy</p> </li> <li> <p>Respiratory distress syndrome</p> </li> <li> <p>Hypoglycaemia</p> </li> <li> <p>Hyperbilirubinaemia</p> </li> <li> <p>Hypocalcaemia</p> </li> <li> <p>Polycythaemia</p> </li> <li> <p>Infection</p> </li> <li> <p>Relevant biomarker changes associated with the intervention (e.g. cord C peptide, cord insulin) </p> </li> </ul> </p> </section> <section id="CD007724-sec-0047"> <h6 class="title">Child/adult</h6> <p> <ul id="CD007724-list-0007"> <li> <p>Weight and Z scores</p> </li> <li> <p>Height and Z scores</p> </li> <li> <p>Head circumference and Z scores</p> </li> <li> <p>Adiposity (e.g. as measured by BMI, skinfold thickness)</p> </li> <li> <p>Cardiovascular health (as defined by trialists including blood pressure, hypertension, cardiovascular disease, metabolic syndrome) </p> </li> <li> <p>Type 1 diabetes</p> </li> <li> <p>Type 2 diabetes</p> </li> <li> <p>Impaired glucose tolerance</p> </li> <li> <p>Employment, education and social status/achievement</p> </li> </ul> </p> </section> <section id="CD007724-sec-0048"> <h6 class="title">Health service</h6> <p> <ul id="CD007724-list-0008"> <li> <p>Number of hospital or health professional visits (e.g. midwife, obstetrician, physician, dietitian, diabetic nurse) </p> </li> <li> <p>Number of antenatal visits or admissions</p> </li> <li> <p>Length of antenatal stay</p> </li> <li> <p>Neonatal intensive care unit/nursery admission</p> </li> <li> <p>Duration of stay in neonatal intensive care unit/nursery</p> </li> <li> <p>Length of postnatal stay (mother)</p> </li> <li> <p>Length of postnatal stay (baby)</p> </li> <li> <p>Costs to families associated with the management provided</p> </li> <li> <p>Costs associated with the intervention</p> </li> <li> <p>Cost of maternal care</p> </li> <li> <p>Cost of offspring care</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD007724-sec-0049"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD007724-sec-0050"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (31 October 2016). </p> <p>The Register is a database containing over 23,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the ‘<b><i>Specialized Register</i> </b> ’ section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD007724-list-0009"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD007724-bbs1-0001" title="">Included studies</a>; <a href="./references#CD007724-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD007724-bbs1-0003" title="">Studies awaiting classification</a>; <a href="./references#CD007724-bbs1-0004" title="">Ongoing studies</a>). </p> </section> <section id="CD007724-sec-0051"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD007724-sec-0052"> <h3 class="title" id="CD007724-sec-0052">Data collection and analysis</h3> <p>For methods used in the previous version of this review, <i>see</i><a href="./references#CD007724-bbs2-0103" title="TieuJ , CoatS , HagueW , MiddletonP . Oral anti‐diabetic agents for women with pre‐existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD007724.pub2] ">Tieu 2010</a>. </p> <p>For this update, the following methods were used for assessing the 29 new reports that were identified as a result of the updated search, and four reports that were reassessed from the previous version of this review. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD007724-sec-0053"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed all the potential studies identified as a result of the search strategy for inclusion. We resolved any disagreement through discussion or, if required, we consulted the third review author. </p> </section> <section id="CD007724-sec-0054"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager 5 software (<a href="./references#CD007724-bbs2-0089" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and checked for accuracy. </p> <p>When information regarding eligibility or data was unclear, we planned to contact authors of the original reports to provide further details. </p> </section> <section id="CD007724-sec-0055"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007724-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD007724-sec-0056"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>For each included study we assessed the method as being at:</p> <p> <ul id="CD007724-list-0010"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007724-sec-0057"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>For each included study we described the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as being at:</p> <p> <ul id="CD007724-list-0011"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007724-sec-0058"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>For each included study we described the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding was unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as being at:</p> <p> <ul id="CD007724-list-0012"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD007724-sec-0059"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>For each included study we described the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as being at:</p> <p> <ul id="CD007724-list-0013"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007724-sec-0060"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>For each included study, and for each outcome or class of outcomes, we described the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses that we undertook. </p> <p>We assessed methods as being at:</p> <p> <ul id="CD007724-list-0014"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007724-sec-0061"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>For each included study we described how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as being at:</p> <p> <ul id="CD007724-list-0015"> <li> <p>low risk of bias (where it was clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s prespecified outcomes were reported; one or more reported primary outcomes were not prespecified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007724-sec-0062"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>For each included study we described any important concerns we had about other possible sources of bias. </p> </section> <section id="CD007724-sec-0063"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007724-bbs2-0060" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it was likely to have an impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses (<a href="#CD007724-sec-0079">Sensitivity analysis</a>). </p> </section> <section id="CD007724-sec-0064"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update the quality of the evidence was assessed using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> for the following outcomes. </p> <section id="CD007724-sec-0065"> <h6 class="title">Mother</h6> <p> <ul id="CD007724-list-0016"> <li> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </li> <li> <p>Caesarean section</p> </li> <li> <p>Gestational diabetes mellitus or type 2 diabetes (if applicable)</p> </li> <li> <p>Induction of labour</p> </li> <li> <p>Perineal trauma</p> </li> <li> <p>Postnatal depression</p> </li> <li> <p>Postnatal weight retention or return to prepregnancy weight</p> </li> </ul> </p> </section> <section id="CD007724-sec-0066"> <h6 class="title">Infant/child/adult</h6> <p> <ul id="CD007724-list-0017"> <li> <p>Large‐for‐gestational age</p> </li> <li> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </li> <li> <p>Neonatal mortality or morbidity composite (e.g. perinatal mortality, shoulder dystocia, bone fracture, and admission to the neonatal unit) </p> </li> <li> <p>Hypoglycaemia</p> </li> <li> <p>Childhood/adulthood neurosensory disability</p> </li> <li> <p>Childhood/adulthood adiposity</p> </li> <li> <p>Childhood/adulthood diabetes</p> </li> </ul> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5 in order to create ’Summary of findings’ tables. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach, which uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates, or potential publication bias. </p> </section> </section> </section> <section id="CD007724-sec-0067"> <h4 class="title">Measures of treatment effect</h4> <section id="CD007724-sec-0068"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD007724-sec-0069"> <h5 class="title">Continuous data</h5> <p>We used the mean difference where outcomes were measured in the same way between trials. We planned to use the standardised mean difference to combine trials that measured the same outcome through different methods. </p> </section> </section> <section id="CD007724-sec-0070"> <h4 class="title">Unit of analysis issues</h4> <section id="CD007724-sec-0071"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials. In future updates of the review, if cluster‐randomised trials are included, we will adjust their sample sizes using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We consider it reasonable to combine the results from both if there is little heterogeneity between the study designs, and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and we will perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD007724-sec-0072"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials are an inappropriate design for this intervention.</p> <p>Cross over trials are not a suitable design for trials looking at interventions in labour and have been excluded. </p> </section> <section id="CD007724-sec-0073"> <h5 class="title">Studies with more than two groups</h5> <p>In <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, results for the group randomised to metformin were reported separately for those women who remained on metformin alone and those women who subsequently received insulin in addition to metformin. We combined the metformin groups to create a single pair‐wise comparison, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 16, section.5.4), by considering the metformin alone and the metformin plus insulin groups together. </p> <p>In <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>, we were unable to report any results from this four‐armed RCT (chlorpropamide, tolbutamide, insulin and diet therapy) as women with type 2 diabetes or gestational diabetes mellitus were not reported separately. However, if we had been able to obtain these data separately, we would have created three single pair‐wise comparisons (by combining both oral anti‐diabetic agents compared with insulin, both oral anti‐diabetic agents compared with diet therapy and one oral anti‐diabetic agent compared with the other anti‐diabetic agent). </p> </section> </section> <section id="CD007724-sec-0074"> <h4 class="title">Dealing with missing data</h4> <p>We noted levels of attrition for included studies. In future updates, if more eligible studies are included, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, that is, we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD007724-sec-0075"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if I² was greater than 30% and either Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. If we identified substantial heterogeneity (above 30%), we planned to explore it by prespecified subgroup analysis. </p> </section> <section id="CD007724-sec-0076"> <h4 class="title">Assessment of reporting biases</h4> <p>As there were fewer than 10 trials included in the analyses, we were unable to investigate reporting biases (such as publication bias) using funnel plots. In future updates, as more data become available, we will investigate reporting biases using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by visual assessment, we will investigate further. </p> </section> <section id="CD007724-sec-0077"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using Review Manager 5 software (<a href="./references#CD007724-bbs2-0089" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: that is, where trials were examining the same intervention, and the trials’ populations and methods were judged to be sufficiently similar. </p> <p>In future updates, with more included studies, if there is clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we will use random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials is considered clinically meaningful. The random‐effects summary will be treated as the average of the range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials. Where we use random‐effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD007724-sec-0078"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out the following subgroup analyses but there were insufficient data to do so. </p> <p> <ul id="CD007724-list-0018"> <li> <p>Type of diabetes (e.g. established type 1 diabetes mellitus versus established type 2 diabetes mellitus versus impaired glucose tolerance versus previous gestational diabetes mellitus). </p> </li> <li> <p>Gestational age of women at randomisation (e.g. preconception versus first trimester versus second trimester versus third trimester). </p> </li> <li> <p>Glycaemic control prior to pregnancy/randomisation (e.g. glycaemic targets achieved versus not achieved). </p> </li> </ul> </p> <p>We planned to use only primary outcomes in subgroup analyses. In future updates, we plan to assess differences between subgroups by interaction tests available in <a href="./references#CD007724-bbs2-0089" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>. We will report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD007724-sec-0079"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out sensitivity analyses to explore the effect of trial quality assessed by concealment of allocation, high attrition rates, or both, with poor‐quality studies (rated at unclear or high risk of bias for these components) being excluded from the analyses in order to assess whether this made any difference to the overall result, however there were insufficient data to do this. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007724-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007724-sec-0080"></div> <section id="CD007724-sec-0081"> <h3 class="title">Description of studies</h3> <section id="CD007724-sec-0082"> <h4 class="title">Results of the search</h4> <p>In the previous version on this review we identified no trials eligible for inclusion (<a href="./references#CD007724-bbs2-0103" title="TieuJ , CoatS , HagueW , MiddletonP . Oral anti‐diabetic agents for women with pre‐existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD007724.pub2] ">Tieu 2010</a>). </p> <p>An updated search was carried out in October 2016; 29 new reports were identified. We reassessed three studies (four reports) which were either excluded (<a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>), ongoing (<a href="./references#CD007724-bbs2-0015" title="ACTRN12610000157077 . Metformin in the prevention of gestational diabetes: the MPG trial. anzctr.org.au/trial_view.aspx?ID=320961 (first received 16 February 2010). ">Hague 2010</a>), or awaiting assessment (<a href="./references#CD007724-bbs2-0030" title="HutchinsonA , HaugabrookC , LongL , MasonL , KipikasaJ , AdairD . A comparison of glyburide/metformin and insulin for gestational diabetes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S200. NCT00371306 . Comparison of glucovance to insulin for diabetes during pregnancy. clinicaltrials.gov/ct2/show/NCT00371306 (first received 1 September 2006). ">Hutchinson 2008</a>) in the previous version. Some studies were published in multiple reports. In total, we have now included six studies and excluded 22. Four studies are awaiting further classification, and three studies are ongoing. See <a href="#CD007724-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD007724-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD007724-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>To date, three of the four studies awaiting further classification have been published as abstracts only (<a href="./references#CD007724-bbs2-0029" title="CoinerJ , RoweM , DeVenteJ . The treatment of diabetes in pregnancy; metformin vs glyburide and insulin biomedical evidence of fetopathy. American Journal of Obstetrics and Gynecology2014; Vol. 210, issue 1 Suppl 1:S148. ">Coiner 2014</a>; <a href="./references#CD007724-bbs2-0030" title="HutchinsonA , HaugabrookC , LongL , MasonL , KipikasaJ , AdairD . A comparison of glyburide/metformin and insulin for gestational diabetes. American Journal of Obstetrics and Gynecology2008;199(6 Suppl 1):S200. NCT00371306 . Comparison of glucovance to insulin for diabetes during pregnancy. clinicaltrials.gov/ct2/show/NCT00371306 (first received 1 September 2006). ">Hutchinson 2008</a>; <a href="./references#CD007724-bbs2-0031" title="Reyes‐MunozE , Ortega‐GonzalezC , Mier‐CabreraJ , Avila‐CarrascoA , EspinoS , Ayala‐YanezR . Medical nutrition therapy plus metformin for preventing gestational diabetes among high‐risk women. Obstetrics and Gynecology2014;123 Suppl 1:168S. ">Reyes‐Munoz 2014</a>); we have contacted the trial authors regarding availability of full reports in order to assess study eligibility and risk of bias further. The fourth study provided insufficient detail for us to determine study eligibility (specifically regarding whether women with established diabetes were included) (<a href="./references#CD007724-bbs2-0032" title="WaheedS , MalikFP , MazharSB . Efficacy of metformin versus insulin in the management of pregnancy with diabetes. Journal of the College of Physicians and Surgeons‐‐Pakistan2013;23(12):866‐9. ">Waheed 2013</a>). For further details see <a href="./references#CD007724-sec-0135" title="">Characteristics of studies awaiting classification</a>. </p> <p>The three ongoing trials are all assessing metformin in pregnant women with type 2 diabetes (<a href="./references#CD007724-bbs2-0033" title="FeigDS , MurphyK , AsztalosE , TomlinsonG , SanchezJ , ZinmanB , et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi‐center randomized controlled trial. BMC Pregnancy and Childbirth2016;16(1):173. NCT01353391 . Metformin in women with type 2 diabetes in pregnancy a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01353391 (first received 2 May 2011). ">Feig 2011</a>), gestational diabetes or type 2 diabetes (<a href="./references#CD007724-bbs2-0034" title="NCT00414245 . Metformin for the treatment of diabetes in pregnancy. clinicaltrials.gov/ct2/show/record/NCT00414245 (first received 20 December 2006). ">Sheizaf 2006</a>), or at high risk for gestational diabetes (<a href="./references#CD007724-bbs2-0035" title="NCT02275845 . Metformin vs control to prevent gestational diabetes mellitus (GDM) in women with a high risk for GDM, an open label randomized controlled trial. The Medico‐GDM trial. clinicaltrials.gov/ct2/show/NCT02275845 (first received 23 October 2014). ">Van der Linden 2014</a>). For further details see <a href="./references#CD007724-sec-0136" title="">Characteristics of ongoing studies</a>. </p> </section> <section id="CD007724-sec-0083"> <h4 class="title">Included studies</h4> <p>We included six trials in this review (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). However, as three of the trials had mixed populations (women with gestational diabetes and women with established diabetes) (<a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>), and did not report data separately for the relevant subset of women for this review, we have only included outcome data from three of the included trials (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). The <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> trial also had a mixed population, but the trial authors provided data for the group of women with established diabetes separately for inclusion in this review. We have contacted the authors of the three trials with mixed populations to ask about the availability of data for women with established diabetes, and await responses. We describe the characteristics of the six included trials below. </p> <section id="CD007724-sec-0084"> <h5 class="title">Settings</h5> <p>The included trials were conducted in Pakistan (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>), Ghana (<a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>), Egypt (<a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>), South Africa (<a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>) and the USA (<a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). </p> <section id="CD007724-sec-0085"> <h6 class="title">Dates when study conducted</h6> <p><a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> was conducted from January 2009 to January 2014, <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a> from January 2013 to October 2015, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> from July 2008 to December 2009, <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a> from August 2011 to April 2012, and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> from September 2009 to August 2011. <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a> did not report when the study was conducted. </p> </section> <section id="CD007724-sec-0086"> <h6 class="title">Funding</h6> <p>Funding sources were reported by four of the trials; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> were funded by non‐commercial organisations; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a> was funded by a commercial organisation (Pfizer Laboratories Ltd); and <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a> identified the trialists as the source of funding. <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> did not describe source of funding and <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a> reported “no source of funding”. </p> </section> <section id="CD007724-sec-0087"> <h6 class="title">Declarations of interest</h6> <p>Three of the trials reported that there were no conflicts of interests for any of the authors (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>). The remaining three trials did not report any information regarding declarations of interest (<a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). </p> </section> </section> <section id="CD007724-sec-0088"> <h5 class="title">Participants</h5> <p>Overall, the six trials randomised 707 women and their babies, with sample sizes ranging from 25 women in <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> to 250 women in <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>. </p> <p>Two trials included only women with established diabetes; both included women with singleton pregnancies, with type 2 diabetes diagnosed prior to pregnancy, and cases of newly diagnosed overt diabetes in pregnancy beyond the first trimester (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>), or a self‐reported history of type 2 diabetes for less than 10 years prior to 20 weeks' gestation (<a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). </p> <p>Four trials included mixed populations of women with gestational diabetes and established type 2 diabetes, prior to 20 weeks' gestation (<a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>), from 20 to 30 weeks' gestation (<a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>), between 20 and 34 weeks' gestation (<a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>), or whose duration of pregnancy would allow at least six consecutive weeks of treatment (<a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>). </p> </section> <section id="CD007724-sec-0089"> <h5 class="title">Interventions</h5> <p>While five of the six included trials compared metformin with insulin (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), their intervention and control regimens varied. Four of the trials assessed 500 mg metformin daily (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), which was increased, as required, up to a maximum of 2500 mg daily in the intervention group. In these four trials, if glycaemic control (variously defined) was not achieved with the maximum dose of metformin, insulin was added as supplementary therapy. In the fifth trial (<a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>), women commenced on 1500 mg metformin daily, which was raised to 2000 mg daily. In this trial, if glycaemic control was not achieved women were switched to a conventional insulin dose‐raising regimen (<a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>). Insulin regimens in the comparison groups were broadly similar; it was commonly given in two doses, with the total daily dose titrated to achieve glycaemic control. Total daily doses were calculated as follows: in <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> 0.6 IU/kg body weight in first trimester, 0.7 IU/kg in second trimester, 0.8 IU/kg from 28 to 32 weeks, 0.9 IU/kg from 32 to 36 weeks, 1 IU/kg from 36 weeks onwards; in <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a> 0.3 IU/kg body weight at initiation (20 to 30 weeks' gestation); in <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> 0.7 IU/kg bodyweight at initiation (prior to 20 weeks' gestation); and in <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>: 0.7 IU/kg bodyweight in the first trimester, 0.8 IU/kg in the second trimester, and 0.9 to 1.0 IU/kg/day in the third trimester. <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a> treated women with poor glycaemic control with a daily dose of at least 1.12 IU/kg bodyweight. </p> <p>The <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a> trial had four groups that compared chlorpropamide, tolbutamide, insulin and diet restriction alone; no further details were provided regarding specific regimens. </p> <p>For detailed descriptions of the included studies, see <a href="./references#CD007724-sec-0133" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD007724-sec-0090"> <h4 class="title">Excluded studies</h4> <p>We excluded a total of 22 studies. Seventeen of the trials evaluated treatments for gestational diabetes (<a href="./references#CD007724-bbs2-0007" title="AnjalakshiC , BalajiV , BalajiMS , SeshiahV . A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Research and Clinical Practice2007;76(3):474‐5. ">Anjalakshi 2007</a>; <a href="./references#CD007724-bbs2-0008" title="BertiniAM , SilvaJC , TabordaW , BeckerF , BebberFR , ViesiJM , et al. Perinatal outcomes and the use of oral hypoglycemic agents. Journal of Perinatal Medicine2005;33(6):519‐23. ">Bertini 2005</a>; <a href="./references#CD007724-bbs2-0010" title="CaseyBM , DuryeaEL , Abbassi‐GhanavatiM , TudelaCM , ShivversSA , McIntireDD , et al. Glyburide in women with mild gestational diabetes: a randomized controlled trial. Obstetrics and Gynecology2015;126(2):303‐9. ">Casey 2015</a>; <a href="./references#CD007724-bbs2-0011" title="CorradoF , D'AnnaR , diG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. ">Corrado 2011</a>; <a href="./references#CD007724-bbs2-0012" title="GeorgeA , MathewsJE , SamD , BeckM , BenjaminSJ , AbrahamA , et al. Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide ‐ a randomised controlled trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2015;55(1):47‐52. ">George 2015</a>; <a href="./references#CD007724-bbs2-0013" title="NCT00160485 . Glyburide compared to insulin in the management of White's classification A2 gestational diabetes. clinicaltrials.gov/ct2/show/NCT00160485 (first received 8 September 2005). ">Golladay 2005</a>; <a href="./references#CD007724-bbs2-0014" title="HagueWM , DavorenPM , OliverJ , RowanJ . Contraindications to use of metformin. Metformin may be useful in gestational diabetes [comment]. BMJ2003; Vol. 326:762. ">Hague 2003</a>; <a href="./references#CD007724-bbs2-0016" title="LangerO , ConwayD , BerkusM , XenakisEM . Oral hypoglycaemic agent is comparable to insulin in GDM management. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S6. LangerO , ConwayDL , BerkusMD , XenakisEM , GonzalesO . A comparison of glyburide and insulin in women with gestational diabetes mellitus. New England Journal of Medicine2000;343(16):1134‐8. LangerO , YogevY , BrustmanL , RosennB . Is there a relationship between severity of gestational diabetes (GDM) and pregnancy outcome in insulin‐ and glyburide‐treated patients?. American Journal of Obstetrics and Gynecology2003;189(6 Suppl 1):S105. LangerO , YogevY , RosennB , BrustmanL . Glyburide therapy: the relationship between dosage and level of gestational diabetes (GDM) severity. American Journal of Obstetrics and Gynecology2003;189(6 Suppl 1):S105. LangerO , YogevY , XenakisEM , RosennB . Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. American Journal of Obstetrics and Gynecology2005;192(1):134‐9. LetonturierP . Gestational diabetes: an alternative to insulin therapy?. Presse Medicale2001;30:169‐70. ">Langer 2000b</a>; <a href="./references#CD007724-bbs2-0017" title="MartinezP , Abdulhaj MartinezM , Andres NunezP , Garcia LeonP , Lopez SanchezEJ , Gonzalez RamirezAR . A randomized study comparing metformin and insulin in the treatment of gestational diabetes mellitus. Interim results. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):381. ">Martinez 2010</a>; <a href="./references#CD007724-bbs2-0018" title="MooreL , ClokeyD , RobinsonA . A randomized trial of metformin compared to glyburide in the treatment of gestational diabetes. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S92. ">Moore 2005</a>; <a href="./references#CD007724-bbs2-0019" title="MooreL , BrieryC , MartinR , HoodE , BofillJ , MorrisonJ . Metformin (M) vs. insulin (I) in A2 diabetes: a randomized clinical trial [abstract]. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S8. MooreLE , BrieryCM , ClokeyD , MartinRW , WillifordNJ , BofillJA , et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. Journal of Reproductive Medicine2007;52(11):1011‐5. ">Moore 2007</a>; <a href="./references#CD007724-bbs2-0020" title="MukhopadhyayP , BagTS , KyalA , SahaDP , KhalidN . Oral hypoglycemic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. Journal of South Asian Federation of Obstetrics and Gynaecology (SAFOG)2012;4(1):28‐31. ">Mukhopadhyay 2012</a>; <a href="./references#CD007724-bbs2-0022" title="IRCT201105075591N2 . Metformin compared with insulin in control of blood sugar in gestational diabetes mellitus. en.search.irct.ir/view/5930 (first received 31 March 2011). NiromaneshS , AlaviA , SharbafFR , AmjadiN , MoosaviS , AkbariS . Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Research and Clinical Practice2012;98(3):422‐9. ">Niromanesh 2012</a>; <a href="./references#CD007724-bbs2-0023" title="RowanJ . A trial in progress: gestational diabetes. Diabetes Care2007;30:S214‐S219. RowanJ . Metformin in gestational diabetes: follow up of offspring of mothers treated with insulin compared with metformin. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=335 (first received 6 September 2005). RowanJA , GaoW , HagueWM , McIntyreHD . Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care2010;33(1):9‐16. RowanJA , HagueWM , GaoW , BattinMR , MooreMP , for the MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. New England Journal of Medicine2008;358(19):2003‐15. RowanJA , RushEC , ObolonkinV , BattinM , WouldesT , HagueWM . Metformin in gestational diabetes: the offspring follow‐up (MiG TOFU): body composition at 2 years of age. Diabetes Care2011;34(10):2279‐84. ">Rowan 2008b</a>; <a href="./references#CD007724-bbs2-0024" title="CTRI/2011/08/001956 . Can oral medication replace insulin injections in pregnant women with diabetes. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=3378 (first received 19 August 2011). ">Singh 2011</a><a href="./references#CD007724-bbs2-0027" title="ACTRN12612001272886 . A phase three open label randomized controlled trial to compare the efficacy of oral hypoglycemic agents (OHA) with insulin in the treatment of gestational diabetes mellitus (GDM). anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363218 (first received 7 December 2012). ">Wali 2012</a>; <a href="./references#CD007724-bbs2-0028" title="ZangenehM . The comparative study of therapeutic effects of insulin and glibenclamide in the gestational diabetes mellitus. http://en.search.irct.ir/view/4374 (first received 1 December 2010). ">Zanganeh 2010</a>), and one assessed treatments for women with hyperglycaemia that did not meet the criteria for gestational diabetes (<a href="./references#CD007724-bbs2-0021" title="ISRCTN86503951 . Management of mild gestational diabetes mellitus (GDM). isrctn.com/ISRCTN86503951 (first received 23 December 2013). ">Myers 2013</a>); these trials are, or will be, considered in the other relevant Cochrane Reviews. Three trials evaluated treatment specifically for women with polycystic ovary syndrome (<a href="./references#CD007724-bbs2-0009" title="CarlsenSM , KjotrodS , VankyE , RomundstadP . Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica2007;86(2):145‐50. ">Carlsen 2007</a>; <a href="./references#CD007724-bbs2-0025" title="SalvesenKA , VankyE , CarlsenSM . Metformin treatment in pregnant women with polycystic ovary syndrome ‐ is reduced complication rate mediated by changes in the uteroplacental circulation?. Ultrasound in Obstetrics and Gynecology2007;29(4):433‐7. VankyE , SalvesenKA , BjerveK , CarlsenSM . C‐Reactive protein in metformin treated pregnant PCOS women. XXXIV Congress of Nordic Federation of Societies of Obstetrics and Gynecology; 2004 June 12‐15;Helsinki, Finland. 2004:76. VankyE , SalvesenKA , HeimstadR , FougnerKJ , RomundstadP , CarlsenSM . Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Human Reproduction2004;19(8):1734‐40. VankyE , SalvesenKA , Hjorth‐HansenH , BjerveK , CarlsenSM . Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C‐reactive protein levels or indices of coagulation. Fertility &amp; Sterility2006;85(3):770‐4. ">Vanky 2004</a>; <a href="./references#CD007724-bbs2-0026" title="NCT00159536 . Metformin in pregnant PCOS women. clinicaltrials.gov/ct2/show/NCT00159536 (first received 8 September 2005). ">Vanky 2005</a>). One potentially relevant trial was planned in women with previous gestational diabetes, but subsequently not conducted (<a href="./references#CD007724-bbs2-0015" title="ACTRN12610000157077 . Metformin in the prevention of gestational diabetes: the MPG trial. anzctr.org.au/trial_view.aspx?ID=320961 (first received 16 February 2010). ">Hague 2010</a>). For further details see <a href="./references#CD007724-sec-0134" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD007724-sec-0091"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall we judged the trials to be at varying risks of bias; see <a href="#CD007724-fig-0002">Figure 2</a> and <a href="#CD007724-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD007724-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD007724-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD007724-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD007724-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD007724-sec-0092"> <h4 class="title">Allocation</h4> <p>We judged that three of the six trials used adequate methods for sequence generation and allocation concealment, and thus were at low risk of selection bias (<a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). One trial reported an adequate method for sequence generation, but the method of allocation concealment was unclear (<a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>). Another trial did not report the methods for sequence generation or allocation concealment (<a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>), and so we judged this trial to be at an unclear risk of selection bias. The final trial used quasi‐randomisation, and we judged it to be at high risk of selection bias (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>). </p> </section> <section id="CD007724-sec-0093"> <h4 class="title">Blinding</h4> <p>We judged all of the six included trials to be at high risk of performance bias (blinding of women and study personnel was not possible due to the nature of the differing treatments received by the intervention and comparison groups) (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). We judged all six trials to be at an unclear risk of detection bias; three trials were reported to be 'open label', but none of these trials specifically reported on whether it was possible to blind outcome assessment (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), and the other three trials provided no details (<a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>). </p> </section> <section id="CD007724-sec-0094"> <h4 class="title">Incomplete outcome data</h4> <p>We judged only one trial to be at low risk of attrition bias (<a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>), as over 90% of the women randomised were included in the analyses, and loss to follow‐up and exclusions occurred in similar numbers, and for similar reasons between groups. We judged two trials to be at an unclear risk of attrition bias; in <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a> there appeared to be higher attrition in the insulin group, with 75% of women completing the study, compared with 90% in the metformin group; and in <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> only 84% of the women randomised were analysed (21/25). We judged three trials to be at a high risk of attrition bias (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>); in <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> almost 20% of women were excluded from the analyses, and notably, in the analyses, the metformin group was separated into metformin alone, and metformin plus insulin; we combined these groups for the purpose of this review. <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a> reported that 'per‐protocol treatment analyses' were performed (with women who chose to switch from their allocated group excluded from the analyses); and for <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a> it also appeared that analyses were not intention‐to‐treat, as it was reported that, "In the final analysis" women were analysed in the group in which they "completed treatment" or "were treated with for the greater part of their pregnancy". </p> </section> <section id="CD007724-sec-0095"> <h4 class="title">Selective reporting</h4> <p>We judged only one trial to be at a low risk of reporting bias, as the expected outcomes were reported as they were in the trial registration (<a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). We judged four of the trials to be at an unclear risk of reporting bias, due to the provision of limited detail regarding prespecified outcomes in the trial registrations available, or limited reporting of expected outcomes to date, or both (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>). We judged one trial to be at a high risk of reporting bias, as it did not prespecify outcomes, and provided incomplete reporting of some outcomes (<a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>). </p> </section> <section id="CD007724-sec-0096"> <h4 class="title">Other potential sources of bias</h4> <p>We judged all six trials to be at unclear risk of other bias. Four of the trials appeared to have imbalances in baseline characteristics despite randomisation (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), while the other two provided very limited methodological details and information regarding the comparability of groups at baseline (<a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>). </p> </section> </section> <section id="CD007724-sec-0097"> <h3 class="title" id="CD007724-sec-0097">Effects of interventions</h3> <p>See: <a href="./full#CD007724-tbl-0001"><b>Summary of findings for the main comparison</b> Maternal outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</a>; <a href="./full#CD007724-tbl-0002"><b>Summary of findings 2</b> Infant outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</a> </p> <section id="CD007724-sec-0098"> <h4 class="title">Oral anti‐diabetic agent (metformin) versus insulin</h4> <section id="CD007724-sec-0099"> <h5 class="title">Mother: primary outcomes</h5> <section id="CD007724-sec-0100"> <h6 class="title">Hypertensive disorders of pregnancy</h6> <p>Both <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> reported on pre‐eclampsia and overall, there was no clear difference between the metformin and insulin groups (risk ratio (RR) RR 0.63, 95% confidence interval (CI) 0.33 to 1.20; RCTs = 2; participants = 227; very low‐quality evidence; <a href="./references#CD007724-fig-0004" title="">Analysis 1.1</a>). In <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, however, women receiving metformin, were less likely to have pregnancy‐induced hypertension (RR 0.58, 95% CI 0.37 to 0.91; RCTs = 1; participants = 206; low‐quality evidence; <a href="./references#CD007724-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD007724-sec-0101"> <h6 class="title">Caesarean section</h6> <p>Pooling of data from <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> showed that women in the metformin group were less likely to have a caesarean section birth compared with those in the insulin group (RR 0.73, 95% CI 0.61 to 0.88; RCTs = 3; participants = 241; low‐quality evidence; <a href="./references#CD007724-fig-0006" title="">Analysis 1.3</a>). </p> </section> </section> <section id="CD007724-sec-0102"> <h5 class="title">Infant/child/adult</h5> <section id="CD007724-sec-0103"> <h6 class="title">Large‐for‐gestational age</h6> <p>There was no clear difference between the metformin and insulin groups for large‐for‐gestational age infants in <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> (RR 1.12, 95% CI 0.73 to 1.72; RCTs = 1; participants = 206; very low‐quality evidence; <a href="./references#CD007724-fig-0007" title="">Analysis 1.4</a>). </p> </section> <section id="CD007724-sec-0104"> <h6 class="title">Perinatal mortality (stillbirth and neonatal mortality)</h6> <p>There were no perinatal deaths in <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> or <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> (RCTs = 2; participants = 220; very low‐quality evidence; <a href="./references#CD007724-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD007724-sec-0105"> <h6 class="title">Neonatal mortality or morbidity composite</h6> <p><a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> did not report on this outcome. </p> </section> <section id="CD007724-sec-0106"> <h6 class="title">Childhood/adulthood neurosensory disability</h6> <p><a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> did not report on this outcome. </p> </section> <section id="CD007724-sec-0107"> <h6 class="title">Mother: short‐term secondary outcomes</h6> <p>In the metformin group in <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>, one woman experienced a 13‐week intrauterine fetal death attributed to a large subchorionic haematoma noted on ultrasound at 12 weeks (<a href="./references#CD007724-fig-0009" title="">Analysis 1.6</a>). </p> <p>Meta‐analysis of data from <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> showed no clear difference between the metformin and insulin groups for induction of labour on (RR 1.42, 95% CI 0.62 to 3.28; RCTs = 2; participants = 35; very low‐quality evidence; <a href="./references#CD007724-fig-0010" title="">Analysis 1.7</a>). In <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>, no women had postpartum haemorrhage that required treatment (<a href="./references#CD007724-fig-0011" title="">Analysis 1.8</a>). In <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, on average, women in the metformin group gained less weight in pregnancy than those in the insulin group (mean difference (MD) ‐1.30 kg, 95% CI ‐1.57 to ‐1.03; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0012" title="">Analysis 1.9</a>). <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> additionally reported on weight gain during pregnancy (this was presented as groups medians, with interquartile ranges in <a href="./references#CD007724-fig-0013" title="">Analysis 1.10</a>) with results also favouring the metformin group. </p> <p>Adherence to the intervention was assessed in the <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> trial. This showed that women in the metformin group were more likely to report 'never or rarely' forgetting to take their medication (RR 1.37, 95% CI 1.14 to 1.64; RCTs = 1; participants = 206), and were less likely to report forgetting to take their medication two to four times per week (RR 0.45, 95% CI 0.28 to 0.72; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0014" title="">Analysis 1.11</a>). In <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>, there was no clear difference between groups for the proportions of women who had missed appointments (RR 2.00, 95% CI 0.59 to 6.79; RCTs = 1; participants = 15), or who completed more than 50% of their log book (RR 1.90, 95% CI 0.89 to 4.04; RCTs = 1; participants = 15; <a href="./references#CD007724-fig-0015" title="">Analysis 1.12</a>). </p> <p>In <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, women in the metformin group were more likely to report that they would choose metformin in their next pregnancy (RR 7.70, 95% CI 4.52 to 13.14; RCTs = 1; participants = 206), were less likely to report that they would choose insulin (RR 0.07, 95% CI 0.03 to 0.19; RCTs = 1; participants = 206), and were less likely to report that they were 'not sure' which medication they would choose (RR 0.11, 95% CI 0.04 to 0.29; RCTs = 1; participants = 206) compared with women in the insulin group (<a href="./references#CD007724-fig-0016" title="">Analysis 1.13</a>). In the <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> trial (<a href="./references#CD007724-fig-0017" title="">Analysis 1.14</a>), when asked what part of the diabetes treatment they found easy, no women in either the metformin or insulin groups reported that doing finger pricks was easy; no women in the metformin group, compared with 25/100 in the insulin group reported that dietary control was easy (RR 0.02, 95% CI 0.00 to 0.30; RCTs = 1; participants = 206), though more women in the metformin group reported that drug treatment was easy (RR 1.33, 95% CI 1.19 to 1.49; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0017" title="">Analysis 1.14</a>). In the <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> trial (<a href="./references#CD007724-fig-0018" title="">Analysis 1.15</a>), when asked what part of the diabetes treatment they found difficult, women in the metformin group were more likely to report that doing finger pricks was difficult (RR 3.46, 95% CI 2.42 to 4.95; RCTs = 1; participants = 206), and were less likely to report that drug treatment was difficult (RR 0.14, 95% CI 0.08 to 0.26; RCTs = 1; participants = 206) compared with women in the insulin group; there was no clear difference in the proportion of women finding diet control difficult in the metformin and insulin groups (RR 0.75, 95% CI 0.31 to 1.84; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0018" title="">Analysis 1.15</a>). In <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> women in the metformin group were more likely to report that they would choose the same treatment in the future (RR 11.14, 95% CI 0.78 to 159.58; RCTs = 1; participants = 11; P = 0.08; <a href="./references#CD007724-fig-0019" title="">Analysis 1.16</a>). </p> <p>Regarding adverse effects of the intervention, in the <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> trial, six women in the metformin group had gastrointestinal side effects resulting in dose limitation compared with none in the insulin group (RR 12.27, 95% CI 0.70 to 215.04; RCTs = 1; participants = 206). No women in either the metformin or insulin groups had gastrointestinal side effects that resulted in treatment cessation or lactic acidosis (<a href="./references#CD007724-fig-0020" title="">Analysis 1.17</a>). </p> <p>There was no clear difference between groups in <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> for exclusive breastfeeding (time point not clear) (RR 1.59, 95% CI 0.79 to 3.23; RCTs = 1; participants = 11; <a href="./references#CD007724-fig-0021" title="">Analysis 1.18</a>). </p> <p>With regard to the need for additional pharmacotherapy, <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> reported that 105/125 women in the metformin group required supplemental insulin to maintain glycaemic control, while <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> reported that none of the 25 women receiving metformin 'failed' with this therapy and needed insulin. <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> reported that 3/9 women in the metformin group required supplemental insulin. </p> <p>In <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, with regard to glycaemic control, there was no clear difference in average fasting (MD 0.01 mg/dL, 95% CI ‐0.90 to 0.92; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0022" title="">Analysis 1.19</a>) or random blood glucose throughout pregnancy (MD ‐0.22 mg/dL, 95% CI ‐1.63 to 1.19; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0023" title="">Analysis 1.20</a>). Similarly, in <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>, there were no clear differences between groups in the average change in HbA1c from enrolment to the third trimester or birth (MD ‐0.48%, 95% CI ‐1.05 to 0.09; RCTs = 1; participants = 21; <a href="./references#CD007724-fig-0024" title="">Analysis 1.21</a>), or in the proportion of women with HbA1c less than 7% in the third trimester or at birth (RR 1.03, 95% CI 0.76 to 1.39; RCTs = 1; participants = 18; <a href="./references#CD007724-fig-0025" title="">Analysis 1.22</a>). <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> reported on glycaemic control (HbA1c in the second and third trimester, delivery glucose, and postpartum fasting glucose), which has been presented as group medians, with interquartile ranges in <a href="./references#CD007724-fig-0026" title="">Analysis 1.23</a>. </p> <p><a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> did not report on: gestational diabetes mellitus*; perinatal trauma; placental abruption; postpartum infection; sense of well‐being and quality of life; hypoglycaemia; mortality; or complications of diabetes. </p> <p><i>*Outcome not relevant to trials involving women with established diabetes prior to pregnancy and pre‐existing diabetes in pregnancy</i> </p> </section> </section> <section id="CD007724-sec-0108"> <h5 class="title">Mother: long‐term secondary outcomes</h5> <p><a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> did not report on: postnatal depression; postnatal weight retention or return to prepregnancy weight; body mass index; gestational diabetes in a subsequent pregnancy*; type 1 diabetes*; type 2 diabetes*; impaired glucose tolerance*; and cardiovascular health. </p> <p><i>*Outcome not relevant to trials involving women with established diabetes prior to pregnancy and pre‐existing diabetes in pregnancy</i> </p> </section> <section id="CD007724-sec-0109"> <h5 class="title">Infant: secondary outcomes</h5> <p>There were no congenital anomalies (major malformations) in <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> (<a href="./references#CD007724-fig-0027" title="">Analysis 1.24</a>). There were no stillbirths or neonatal deaths in <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> or <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> (<a href="./references#CD007724-fig-0028" title="">Analysis 1.25</a>; <a href="./references#CD007724-fig-0029" title="">Analysis 1.26</a>). <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> did not show a clear difference in gestational age at birth between the metformin and insulin groups (MD ‐0.30 weeks, 95% CI ‐0.66 to 0.06; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0030" title="">Analysis 1.27</a>); <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> also reported on gestational age (presented as group medians, with (interquartile) ranges in <a href="./references#CD007724-fig-0031" title="">Analysis 1.28</a>). There was no clear difference between the metformin and insulin groups for preterm birth in <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> (RR 0.42, 95% CI 0.08 to 2.30; RCTs = 2; participants = 35; <a href="./references#CD007724-fig-0032" title="">Analysis 1.29</a>). No infants had an Apgar score less than seven at five minutes in <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> (<a href="./references#CD007724-fig-0033" title="">Analysis 1.30</a>). There were no clear differences for macrosomia (&gt; 4000 g) (RR 0.37, 95% CI 0.04 to 3.10; RCTs = 2; participants = 35; <a href="./references#CD007724-fig-0034" title="">Analysis 1.31</a>) in <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>. </p> <p>In <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> infants born to mothers in the metformin group were more likely to be small‐for‐gestational age compared with those born to mothers in the insulin group (RR 8.49, 95% CI 2.02 to 35.66; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0035" title="">Analysis 1.32</a>). Meta‐analysis of data from <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> showed no clear difference for birthweight between infants born to mothers in the metformin and insulin groups (MD ‐0.13 kg, 95% CI ‐0.29 to 0.04; RCTs = 2; participants = 227; <a href="./references#CD007724-fig-0036" title="">Analysis 1.33</a>). <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> also reported on birthweight, head circumference, length and cord C peptide (these data are presented as group medians, with interquartile ranges in <a href="./references#CD007724-fig-0037" title="">Analysis 1.34</a>; <a href="./references#CD007724-fig-0038" title="">Analysis 1.35</a>; <a href="./references#CD007724-fig-0039" title="">Analysis 1.36</a>; <a href="./references#CD007724-fig-0047" title="">Analysis 1.44</a>). </p> <p>There were no clear differences between the metformin and insulin groups for shoulder dystocia (RR 4.67, 95% CI 0.21 to 102.47; RCTs = 2; participants = 35; <a href="./references#CD007724-fig-0040" title="">Analysis 1.37</a>) in <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>, or across <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> and <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> in the proportion of infants with clavicle fracture or birth injury (RR 0.94, 95% CI 0.14 to 6.57; RCTs = 2; participants = 220; <a href="./references#CD007724-fig-0041" title="">Analysis 1.38</a>). However, infants in the metformin group were less likely to have hyperbilirubinaemia or jaundice (RR 0.44, 95% CI 0.24 to 0.81; RCTs = 2; participants = 220; <a href="./references#CD007724-fig-0044" title="">Analysis 1.41</a>), or sepsis (RR 0.26, 95% CI 0.08 to 0.81; RCTs = 2; participants = 220; <a href="./references#CD007724-fig-0045" title="">Analysis 1.42</a>). </p> <p>Meta‐analysis of data from <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> showed no clear difference between groups for respiratory distress syndrome (RR 0.52, 95% CI 0.24 to 1.13; RCTs = 3; participants = 241; <a href="./references#CD007724-fig-0042" title="">Analysis 1.39</a>). Infants born to mothers in the metformin group were less likely to have hypoglycaemia (RR 0.34, 95% CI 0.18 to 0.62; RCTs = 3; participants = 241; very low‐quality evidence; <a href="./references#CD007724-fig-0043" title="">Analysis 1.40</a>). However, in <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, infants born to women in the metformin group had, on average, higher blood glucose at birth (MD 3.57 mg/dL, 95% CI 0.26 to 6.88; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0046" title="">Analysis 1.43</a>). </p> <p><a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> did not report on: ponderal index; adiposity; nerve palsy; hypocalcaemia; or polycythaemia. </p> </section> <section id="CD007724-sec-0110"> <h5 class="title">Child/adult: secondary outcomes</h5> <p><a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> did not report on: weight; height; head circumference; adiposity; cardiovascular health; type 1 diabetes; type 2 diabetes; impaired glucose tolerance; employment, education and social status/achievement. </p> </section> <section id="CD007724-sec-0111"> <h5 class="title">Health service: secondary outcomes</h5> <p>In <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> there was no clear difference in antenatal hospital admissions between groups (RR 0.22, 95% CI 0.03 to 1.66; RCTs = 1; participants = 15; <a href="./references#CD007724-fig-0048" title="">Analysis 1.45</a>). Meta‐analysis of data from <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> showed that infants born to mothers who received metformin compared with insulin were less likely to be admitted to the neonatal intensive care unit (RR 0.37, 95% CI 0.27 to 0.52; RCTs = 3; participants = 241; <a href="./references#CD007724-fig-0049" title="">Analysis 1.46</a>). In <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> there was no clear difference reported in length of postnatal stay for the infants (reported as median and range) (<a href="./references#CD007724-fig-0050" title="">Analysis 1.47</a>). <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> reported that the three neonates who were admitted to the neonatal intensive care unit in the insulin group had lengths of stay of: five days, three to four weeks and 46 days. </p> <p>In <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, total costs of treatment throughout pregnancy were, on average, lower for women in the metformin group compared with those in the insulin group (MD ‐65.30 USD, 95% CI ‐77.92 to ‐52.68; RCTs = 1; participants = 206; <a href="./references#CD007724-fig-0051" title="">Analysis 1.48</a>). </p> <p><a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>, <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a> and <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a> did not report on: number of hospital or health professional visits; length of antenatal stay; length of postnatal stay (mother); costs to families associated with the management provided; costs associated with the intervention; or cost of offspring care. </p> </section> <section id="CD007724-sec-0112"> <h5 class="title">Subgroup and sensitivity analyses</h5> <p>We were not able to conduct the planned subgroup analyses or sensitivity analyses due to a paucity of data. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007724-sec-0113" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007724-sec-0113"></div> <section id="CD007724-sec-0114"> <h3 class="title" id="CD007724-sec-0114">Summary of main results</h3> <p>The increasing prevalence and effects of established diabetes on maternal and infant health outcomes highlight the importance of evaluating evidence‐based management for women with established diabetes, impaired glucose tolerance or previous gestational diabetes both preconceptionally and during pregnancy. Additionally, women with impaired glucose tolerance or gestational diabetes in a previous pregnancy represent a group of women with relatively increased insulin resistance, and are at risk of developing type 2 diabetes. Appropriate management of these women is unclear. </p> <p>Six trials were eligible for inclusion in the review (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), but only three trials contributed data and are included in the analyses (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). These three trials provided data for 241 women who had type 2 diabetes diagnosed before, or during, pregnancy, and their infants. </p> <p>For our primary outcomes there was no clear difference between the metformin and insulin groups across two trials for pre‐eclampsia (very low‐quality evidence) (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), although in the <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> trial women receiving metformin were less likely to have pregnancy‐induced hypertension (low‐quality evidence). Women taking metformin were less likely to have a caesarean section birth compared with those taking insulin across the three trials (low‐quality evidence) (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). In <a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a> there was no clear difference between the metformin groups for large‐for‐gestational‐age infants (very low‐quality evidence)<i>.</i> There were no perinatal deaths reported in two trials (very low‐quality evidence) (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>).The trials did not report on neonatal mortality, a morbidity composite outcome, or childhood or adulthood neurosensory disability. </p> <p>For important secondary outcomes, assessed using the GRADE approach, there were no clear differences between groups in the number of women undergoing induction of labour across two trials (very low‐quality evidence) (<a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), though neonatal hypoglycaemia was reduced in the metformin group across the three trials (very low‐quality evidence) (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>). For mothers, perineal trauma, postnatal depression, and postnatal weight retention were not reported, while for infant outcomes, childhood or adulthood adiposity, and childhood or adulthood diabetes, were not reported. </p> <p>Few other of this review's secondary outcomes were reported, however additional benefits were observed for metformin, with less weight gain in pregnancy reported in two trials (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>), improved adherence in one trial (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>), more favourable views of treatment in two trials (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>), less neonatal hyperbilirubinaemia and infection in two trials (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>), less neonatal intensive care unit admission in three trials (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>; <a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), and lower costs of maternal care in one trial (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>); however there were more small‐for‐gestational‐age infants with metformin in one trial (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>). </p> </section> <section id="CD007724-sec-0115"> <h3 class="title" id="CD007724-sec-0115">Overall completeness and applicability of evidence</h3> <p>Though we included six trials in this review, we were not able to include outcome data from three of them (<a href="./references#CD007724-bbs2-0002" title="BeyuoT , ObedSA , Adjepong‐YamoahKK , BugyeiKA , OppongSA , MarfohK . Metformin versus insulin in the management of pre‐gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLOS ONE2015;10(5):e0125712. ">Beyuo 2015</a>; <a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>; <a href="./references#CD007724-bbs2-0005" title="NotelovitzM . Sulphonylurea therapy in the treatment of the pregnant diabetic. South African Medical Journal1971;45:226‐9. ">Notelovitz 1971</a>), as they had mixed populations (women with gestational diabetes and established diabetes) and did not report data separately for the subset of women relevant to this review. Two of the three trials that were able to provide data were from the USA (<a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), and one was from Pakistan (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>). These three trials all compared an oral anti‐diabetic agent (metformin) with insulin, therefore, currently no data are available regarding the comparative effects of oral anti‐diabetic agents versus no treatment, or different oral anti‐diabetic agents. Similarly, no data are available regarding the effects of oral anti‐diabetic agents for women with established type 1 or 2 diabetes mellitus, impaired glucose tolerance or previous gestational diabetes mellitus planning a pregnancy, as the three trials that contributed data all recruited pregnant women with type 2 diabetes diagnosed prior to pregnancy (or cases of newly diagnosed overt diabetes in pregnancy, or both). </p> <p>We selected a number of outcomes for quality assessment using the GRADE approach: while three trials reported on caesarean section, perinatal mortality and neonatal hypoglycaemia, only two reported on pre‐eclampsia and induction of labour, and only one on large‐for‐gestational age infants. There were no data for: perineal trauma, postnatal depression, postnatal weight retention, neonatal mortality or morbidity composite; childhood or adulthood neurosensory disability, or childhood or adulthood diabetes. </p> </section> <section id="CD007724-sec-0116"> <h3 class="title" id="CD007724-sec-0116">Quality of the evidence</h3> <p>Risk of bias in the included studies was mixed. One of the trials contributing data was quasi‐randomised and thus at high risk of selection bias. None of the trials that contributed data were able to blind women or the staff providing care and this may have had an impact on some outcomes. It was not clear in the trials whether there were attempts to blind outcome assessors. In one of the trials that contributed data there was high loss to follow‐up (&gt; 20%) (<a href="./references#CD007724-bbs2-0001" title="AinuddinJA , KarimN , ZaheerS , AliSS , HasanAA . Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel‐group, randomized, open label study in patients with type 2 diabetes in pregnancy. Journal of Diabetes Research2015;2015:325851. NCT01855763 . Metformin in gestational diabetes and type 2 diabetes in pregnancy in a developing country. clinicaltrials.gov/ct2/show/NCT01855763 (first received 9 May 2013). ">Ainuddin 2015</a>). </p> <p>We determined the evidence for outcomes assessed using the GRADE approach to be low quality or very low quality. Evidence was downgraded due to design limitations (risk of bias) and/or imprecision due to small sample sizes, low event rates, and/or uncertain effect estimates. </p> </section> <section id="CD007724-sec-0117"> <h3 class="title" id="CD007724-sec-0117">Potential biases in the review process</h3> <p>We took steps to minimise bias in the review process. Data extraction was carried out by two researchers independently and all data were checked. The GRADE approach assessments were made by two people independently and discrepancies resolved by discussion. We acknowledge that we may have missed relevant trials because we did not formerly search trials registers such as <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> or the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>), which became mandatory after October 2016, but we will search these registers in the next update. </p> </section> <section id="CD007724-sec-0118"> <h3 class="title" id="CD007724-sec-0118">Agreements and disagreements with other studies or reviews</h3> <p>There is a dearth of evidence on the use of oral anti‐diabetic agents for women with established diabetes, impaired glucose tolerance or previous gestational diabetes who are planning a pregnancy, or pregnant women with pre‐existing diabetes. Current evidence focuses on women with gestational diabetes, and we refer readers to the Cochrane Reviews <a href="./references#CD007724-bbs2-0045" title="BrownJ , MartisR , HughesB , RowanJ , CrowtherCA . Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD011967.pub2] ">Brown 2017b</a> and <a href="./references#CD007724-bbs2-0043" title="BrownJ , GrzeskowiakL , WilliamsonK , DownieMR , CrowtherCA . Insulin for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD012037] ">Brown 2016b</a> for assessments of oral anti‐diabetic agents versus no treatment or alternative oral anti‐diabetic agents, and oral anti‐diabetic agents versus insulin, respectively, in women with gestational diabetes. </p> <p>One recent systematic review assessed short‐ and long‐term outcomes of metformin compared with insulin in pregnancy, and included trials in women with gestational diabetes or type 2 diabetes (<a href="./references#CD007724-bbs2-0046" title="ButaliaS , GutierrezL , LodhaA , AitkenE , ZakariasenA , DonovanL . Short‐ and long‐term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta‐analysis. Diabetic Medicine2017;34(1):27‐36. ">Butalia 2017</a>). The review included data from two of the trials that provided outcome data in our review (<a href="./references#CD007724-bbs2-0003" title="HickmanMA , McBrideR , BoggessKA , StraussR . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. American Journal of Perinatology2013;30(6):483‐90. NCT00835861 . Effectiveness of metformin compared to insulin in pregnant women with mild preexisting or early gestational diabetes (MIPOD). clinicaltrials.gov/ct2/show/results/NCT00835861 (first received 2 February 2009). ">Hickman 2013</a>; <a href="./references#CD007724-bbs2-0006" title="NCT00678080 . Metformin versus insulin in pregnant women with type 2 diabetes. clinicaltrials.gov/ct2/show/NCT00678080 (first received 8 May 2008). RefuerzoJS , GowenR , PedrozaC , HutchinsonM , BlackwellSC , RaminS . A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. American Journal of Perinatology2015;32(2):163‐70. ">Refuerzo 2015</a>), one trial included in our review from which we did not include data (<a href="./references#CD007724-bbs2-0004" title="IbrahimMI , HamdyA , ShafikA , TahaS , AnwarM , FarisM . The role of adding metformin in insulin‐resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics2014;289(5):959‐65. NCT01915550 . The role of adding metformin in insulin‐resistant diabetic pregnant women ‐ a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01915550 (first received 2 August 2013). ">Ibrahim 2014</a>), and an additional 13 trials (all in women with gestational diabetes). In agreement with the results of our review, <a href="./references#CD007724-bbs2-0046" title="ButaliaS , GutierrezL , LodhaA , AitkenE , ZakariasenA , DonovanL . Short‐ and long‐term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta‐analysis. Diabetic Medicine2017;34(1):27‐36. ">Butalia 2017</a> reported reductions in pregnancy‐induced hypertension, maternal weight gain in pregnancy, neonatal hypoglycaemia, and neonatal intensive care unit admission with metformin versus insulin, and no clear differences between treatments for pre‐eclampsia, glycaemic control, preterm birth and macrosomia. Conversely, <a href="./references#CD007724-bbs2-0046" title="ButaliaS , GutierrezL , LodhaA , AitkenE , ZakariasenA , DonovanL . Short‐ and long‐term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta‐analysis. Diabetic Medicine2017;34(1):27‐36. ">Butalia 2017</a> reported no clear difference between metformin and insulin for caesarean birth (a reduction with metformin was observed in our review) or small‐for‐gestational age infants (an increase with metformin was observed in our review), and a reduction in large‐for‐gestational age infants (no clear difference was observed in our review).The <a href="./references#CD007724-bbs2-0046" title="ButaliaS , GutierrezL , LodhaA , AitkenE , ZakariasenA , DonovanL . Short‐ and long‐term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta‐analysis. Diabetic Medicine2017;34(1):27‐36. ">Butalia 2017</a> review concluded that while metformin appeared to have short‐term benefits, with no observed harms, information on long‐term benefits and harms is limited, and thus it recommended further follow‐up studies prior to use becoming routine. One of the ongoing trials identified in this review (<a href="./references#CD007724-bbs2-0033" title="FeigDS , MurphyK , AsztalosE , TomlinsonG , SanchezJ , ZinmanB , et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi‐center randomized controlled trial. BMC Pregnancy and Childbirth2016;16(1):173. NCT01353391 . Metformin in women with type 2 diabetes in pregnancy a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT01353391 (first received 2 May 2011). ">Feig 2011</a>), the Metformin in Women with Type 2 Diabetes in Pregnancy Trial (MiTy Trial), which compares the effectiveness of the addition of metformin to insulin with standard care (insulin plus placebo) in pregnant women with type 2 diabetes, will provide these longer‐term data from its planned MiTy Kids two‐year follow‐up (<a href="./references#CD007724-bbs2-0082" title="NCT01832181 . Metformin in women with type 2 diabetes in pregnancy kids trial (MiTy Kids). clinicaltrials.gov/ct2/show/NCT01832181 (first received 8 April 2013). ">NCT01832181</a>). </p> <p>A systematic review of guidelines for the preconception care of women with type 2 diabetes in pregnancy identified that, while all the included guidelines recommended insulin prior to pregnancy to achieve target concentrations of blood glucose, the more recent ones suggested use of metformin as an adjunct or alternative, for example in situations when insulin is refused or a woman develops resistance (<a href="./references#CD007724-bbs2-0078" title="MahmudM , MazzaD . Preconception care of women with diabetes: a review of current guideline recommendations. BMC Women's Health2010;10:5. ">Mahmud 2010</a>). This guideline review noted that while "the safety of currently available oral antidiabetic agents (metformin and glyburide) during pregnancy looks promising, the complete safety and efficacy profile during the full term of pregnancy has not yet been established" (<a href="./references#CD007724-bbs2-0078" title="MahmudM , MazzaD . Preconception care of women with diabetes: a review of current guideline recommendations. BMC Women's Health2010;10:5. ">Mahmud 2010</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007724-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD007724-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD007724-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD007724-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 1 Hypertensive disorders of pregnancy: pre‐eclampsia." data-id="CD007724-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 1 Hypertensive disorders of pregnancy: pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 2 Hypertensive disorders of pregnancy: pregnancy‐induced hypertension." data-id="CD007724-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 2 Hypertensive disorders of pregnancy: pregnancy‐induced hypertension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 3 Caesarean section." data-id="CD007724-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 4 Large‐for‐gestational age." data-id="CD007724-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 4 Large‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 5 Perinatal mortality." data-id="CD007724-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 5 Perinatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 6 Miscarriage." data-id="CD007724-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 6 Miscarriage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 7 Induction of labour." data-id="CD007724-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 7 Induction of labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 8 Postpartum haemorrhage." data-id="CD007724-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 8 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 9 Weight gain in pregnancy (kg)." data-id="CD007724-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 9 Weight gain in pregnancy (kg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0013"> <p> <div class="table" id="CD007724-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metformin (N=9)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Insulin (N=6)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 3.16 (2.88, 4.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 10.78 (8.15, 14.42)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 10 Weight gain in pregnancy (kg). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0013">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007724-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 11 Adherence to the intervention (how often did you forget to take treatment?)." data-id="CD007724-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 11 Adherence to the intervention (how often did you forget to take treatment?). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 12 Adherence to the intervention." data-id="CD007724-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 12 Adherence to the intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 13 Views of the intervention (which medication would you choose in next pregnancy?)." data-id="CD007724-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 13 Views of the intervention (which medication would you choose in next pregnancy?). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 14 Views of the intervention (which part of diabetes treatment was easy?)." data-id="CD007724-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 14 Views of the intervention (which part of diabetes treatment was easy?). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 15 Views of the intervention (which part of diabetes treatment was difficult?)." data-id="CD007724-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 15 Views of the intervention (which part of diabetes treatment was difficult?). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 16 Views of the intervention (choose same treatment in the future)." data-id="CD007724-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 16 Views of the intervention (choose same treatment in the future). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 17 Adverse effects of the intervention (side effects)." data-id="CD007724-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 17 Adverse effects of the intervention (side effects). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 18 Breastfeeding." data-id="CD007724-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 18 Breastfeeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 19 Glycaemic control (fasting blood glucose throughout pregnancy (mg/dL))." data-id="CD007724-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 19 Glycaemic control (fasting blood glucose throughout pregnancy (mg/dL)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 20 Glycaemic control (random blood glucose throughout pregnancy (mg/dL))." data-id="CD007724-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 20 Glycaemic control (random blood glucose throughout pregnancy (mg/dL)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 21 Glycaemic control (change in HbA1c from enrolment to third trimester/birth (%))." data-id="CD007724-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 21 Glycaemic control (change in HbA1c from enrolment to third trimester/birth (%)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 22 Glycaemic control (HbA1c &lt; 7% at third trimester/birth)." data-id="CD007724-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 22 Glycaemic control (HbA1c &lt; 7% at third trimester/birth). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0026"> <p> <div class="table" id="CD007724-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metformin (N=8)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Insulin (N=6)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HbA1c 2nd trimester (%)</p> <p>Median (IQR): 5.55 (5.54, 5.70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HbA1c 2nd trimester (%)</p> <p>Median (IQR): 5.70 (5.35, 6.28)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HbA1c 3rd trimester (%)</p> <p>Median (IQR): 5.85 (5.73, 6.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HbA1c 3rd trimester (%)</p> <p>Median (IQR): 5.85 (5.53, 6.55)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Delivery glucose (mg/dL)</p> <p>Median (IQR): 96.00 (92.00, 113.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Delivery glucose (mg/dL)</p> <p>Median (IQR): 127.50 (109.25, 122.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum fasting glucose (mg/dL)</p> <p>Median (IQR): 97.50 (78.50, 108.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum fasting glucose (mg/dL)</p> <p>Median (IQR): 125.50 (109.75, 136.75)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 23 Glycaemic control. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0026">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007724-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 24 Congenital anomaly (major malformations)." data-id="CD007724-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 24 Congenital anomaly (major malformations). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 25 Stillbirth." data-id="CD007724-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 25 Stillbirth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 26 Neonatal mortality." data-id="CD007724-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 26 Neonatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 27 Gestational age at birth (weeks)." data-id="CD007724-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 27 Gestational age at birth (weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0031"> <p> <div class="table" id="CD007724-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metformin</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Insulin</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>P value</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 38.40 (37.10, 38.86)</p> <p>N=9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 37.50 (35.79, 38.00)</p> <p>N=6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Refuerzo 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (range): 37 (35‐40)</p> <p>N=8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (range): 37 (35‐41)</p> <p>N=13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.977</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 28 Gestational age at birth (weeks). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0031">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007724-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 29 Preterm birth." data-id="CD007724-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 29 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 30 Apgar score &lt; 7 at 5 minutes." data-id="CD007724-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 30 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 31 Macrosomia (&gt; 4000 g)." data-id="CD007724-fig-0034" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 31 Macrosomia (&gt; 4000 g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 32 Small‐for‐gestational age." data-id="CD007724-fig-0035" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 32 Small‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 33 Birthweight (kg)." data-id="CD007724-fig-0036" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 33 Birthweight (kg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0037"> <p> <div class="table" id="CD007724-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metformin (N=8)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Insulin (N=6)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 3071.50 (2978.75, 3237.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 3295.50 (2964.25, 3566.75)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 34 Birthweight (g). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0037">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007724-fig-0038"> <p> <div class="table" id="CD007724-tblf-0005"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metformin (N=8)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Insulin (N=6)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 33.50 (32.48, 34.63)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 33.50 (32.25, 34.75)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 35 Head circumference (cm). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0038">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007724-fig-0039"> <p> <div class="table" id="CD007724-tblf-0006"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metformin (N=8)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Insulin (N=6)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 49.00 (48.07, 50.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 49.50 (48.45, 52.25)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 36 Length (cm). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0039">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007724-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 37 Shoulder dystocia." data-id="CD007724-fig-0040" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 37 Shoulder dystocia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 38 Bone fracture (birth injury/birth trauma with clavicle fracture)." data-id="CD007724-fig-0041" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 38 Bone fracture (birth injury/birth trauma with clavicle fracture). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 39 Respiratory distress syndrome." data-id="CD007724-fig-0042" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 39 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 40 Hypoglycaemia." data-id="CD007724-fig-0043" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 40 Hypoglycaemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 41 Hyperbilirubinaemia (jaundice)." data-id="CD007724-fig-0044" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 41 Hyperbilirubinaemia (jaundice). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 42 Infection (sepsis)." data-id="CD007724-fig-0045" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.42</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 42 Infection (sepsis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 43 Relevant biomarkers (blood glucose level at birth (mg/dL))." data-id="CD007724-fig-0046" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.43</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 43 Relevant biomarkers (blood glucose level at birth (mg/dL)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0047"> <p> <div class="table" id="CD007724-tblf-0007"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metformin (N=6)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Insulin (N=4)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 1.25 (0.92, 1.65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 3.95 (2.78, 5.13)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.44</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 44 Relevant biomarker (cord C peptide). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0047">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007724-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 45 Number of antenatal admissions." data-id="CD007724-fig-0048" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.45</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 45 Number of antenatal admissions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 46 Neonatal intensive care unit admission." data-id="CD007724-fig-0049" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.46</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 46 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007724-fig-0050"> <p> <div class="table" id="CD007724-tblf-0008"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Metformin</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Insulin</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>P value</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Refuerzo 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (range): 3 (1‐8)</p> <p>N=8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (range): 2 (1‐12)</p> <p>N=13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.697</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.47</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 47 Length of postnatal stay (baby) (days). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0050">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007724-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/urn:x-wiley:14651858:media:CD007724:CD007724-CMP-001-48" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_t/tCD007724-CMP-001-48.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 48 Cost of maternal care (total cost of treatment throughout pregnancy (USD))." data-id="CD007724-fig-0051" src="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-48.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.48</div> <div class="figure-caption"> <p>Comparison 1 Oral anti‐diabetic agent (metformin) versus insulin, Outcome 48 Cost of maternal care (total cost of treatment throughout pregnancy (USD)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/media/CDSR/CD007724/image_n/nCD007724-CMP-001-48.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007724-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Maternal outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Maternal outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with type 2 diabetes<br/> <b>Setting:</b> USA (2 RCTs), Pakistan (1 RCT)<br/> <b>Intervention:</b> oral anti‐diabetic agent (metformin)<br/> <b>Comparison:</b> insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oral anti‐diabetic (metformin)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypertensive disorders of pregnancy: pre‐eclampsia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.63<br/> (0.33 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>227<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>186 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117 per 1000<br/> (61 to 223) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypertensive disorders of pregnancy: pregnancy‐induced hypertension</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/> (0.37 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>206<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209 per 1000<br/> (133 to 328) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.73<br/> (0.61 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>241<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>765 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>558 per 1000<br/> (466 to 673) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of labour</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.42<br/> (0.62 to 3.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>35<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>316 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>448 per 1000<br/> (196 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perineal trauma</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Postnatal depression</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported these outcomes</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Postnatal weight retention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported these outcomes</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Study limitations (‐2): most of the weight in this analysis was from 1 RCT with very serious design limitations </p> <p><sup>2</sup> Imprecision (‐2): wide 95% CI crossing the line of no effect and small sample sizes of RCTs </p> <p><sup>3</sup> Study limitations (‐2): 1 RCT with very serious design limitations contributed data </p> <p><sup>4</sup> Study limitations (‐1): 2 RCTs with design limitations contributed data </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Maternal outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007724-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Infant outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Infant outcomes: oral anti‐diabetic (metformin) compared with insulin for women with established diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with type 2 diabetes mellitus<br/> <b>Setting:</b> USA (2 RCTs) and Pakistan (1 RCT)<br/> <b>Intervention:</b> oral anti‐diabetic agent (metformin)<br/> <b>Comparison:</b> insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oral anti‐diabetic (metformin)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Large‐for‐gestational age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.12<br/> (0.73 to 1.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>206<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>270 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>302 per 1000<br/> (197 to 464) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>220<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No perinatal mortality in the 2 RCTs</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypoglycaemia</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.34<br/> (0.18 to 0.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>241<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>277 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>94 per 1000<br/> (50 to 172) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neonatal mortality or morbidity composite</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Childhood/adulthood neurosensory disability</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Childhood/adulthood adiposity</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Childhood/adulthood diabetes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>None of the included RCTs reported this outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Study limitations (‐2): 1 RCT with very serious design limitations contributed data </p> <p><sup>2</sup> Imprecision (‐2): wide 95% CI crossing the line of no effect and small sample size of RCT </p> <p><sup>3</sup> Study limitations (‐1): 2 RCTs with design limitations contributed data </p> <p><sup>4</sup> Imprecision (‐2): no events </p> <p><sup>5</sup> Study limitations (‐2): most of the weight in this analysis was from 1 RCT with very serious design limitations </p> <p><sup>6</sup> Imprecision (‐1): small sample sizes of RCTs </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Infant outcomes: oral anti‐diabetic agent (metformin) compared with insulin for women with established type 2 diabetes mellitus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/full#CD007724-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007724-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oral anti‐diabetic agent (metformin) versus insulin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Hypertensive disorders of pregnancy: pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.33, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Hypertensive disorders of pregnancy: pregnancy‐induced hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.37, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.61, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Large‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.73, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.1 [0.10, 44.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Induction of labour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.62, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Weight gain in pregnancy (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐1.57, ‐1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Weight gain in pregnancy (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Adherence to the intervention (how often did you forget to take treatment?) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Never or rarely</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.14, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 2 to 4 times/week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.28, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Adherence to the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 No missed appointments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.59, 6.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Log book completed &gt; 50%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.9 [0.89, 4.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Views of the intervention (which medication would you choose in next pregnancy?) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Metformin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.70 [4.52, 13.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.03, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Not sure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.04, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Views of the intervention (which part of diabetes treatment was easy?) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Doing finger pricks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Diet control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.00, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 Drug treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.19, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Views of the intervention (which part of diabetes treatment was difficult?) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Doing finger pricks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.46 [2.42, 4.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Diet control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.31, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 Drug treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.08, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Views of the intervention (choose same treatment in the future) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.14 [0.78, 159.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Adverse effects of the intervention (side effects) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Gastrointestinal side effects resulting in dose limitation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.27 [0.70, 215.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Gastrointestinal side effects resulting in treatment cessation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.3 Lactic acidosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Breastfeeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [0.79, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Glycaemic control (fasting blood glucose throughout pregnancy (mg/dL)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.90, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Glycaemic control (random blood glucose throughout pregnancy (mg/dL)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐1.63, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Glycaemic control (change in HbA1c from enrolment to third trimester/birth (%)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐1.05, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Glycaemic control (HbA1c &lt; 7% at third trimester/birth) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.76, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Glycaemic control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Congenital anomaly (major malformations) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Stillbirth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Neonatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Gestational age at birth (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.66, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Gestational age at birth (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.08, 2.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Macrosomia (&gt; 4000 g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.04, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Small‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.49 [2.02, 35.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Birthweight (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.29, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Birthweight (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Head circumference (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Length (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Shoulder dystocia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.67 [0.21, 102.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Bone fracture (birth injury/birth trauma with clavicle fracture) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.14, 6.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.24, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.18, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Hyperbilirubinaemia (jaundice) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.24, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 Infection (sepsis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.08, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 Relevant biomarkers (blood glucose level at birth (mg/dL)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.57 [0.26, 6.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 Relevant biomarker (cord C peptide) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 Number of antenatal admissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.03, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.27, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47 Length of postnatal stay (baby) (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48 Cost of maternal care (total cost of treatment throughout pregnancy (USD)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐65.3 [‐77.92, ‐52.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oral anti‐diabetic agent (metformin) versus insulin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007724.pub3/references#CD007724-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007724.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007724-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007724-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007724-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD007724-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD007724-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD007724-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007724-note-0013">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007724\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007724\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007724\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007724\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007724\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007724.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007724.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007724.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007724.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007724.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718550174"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007724.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718550177"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007724.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd3139d11f401',t:'MTc0MDcxODU1MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 